{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T19:12:04Z","timestamp":1792264324138,"version":"4.4.0"},"reference-count":276,"publisher":"IMR Press","issue":"5","license":[{"start":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T00:00:00Z","timestamp":1779408000000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Il bando si inserisce nelle iniziative finanziate dall\u2019Unione Europea \u2013 Next Generation EU","award":["B55F21007810001"],"award-info":[{"award-number":["B55F21007810001"]}]},{"name":"Project Tuscany Health Ecosystem","award":["B83C22003920001"],"award-info":[{"award-number":["B83C22003920001"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Front. Biosci. (Landmark Ed)"],"abstract":"<jats:p>Increasing evidence suggests that the gut microbiome (GM) may exert a seminal role in the maintenance of host health as well as in the pathogenesis of various illnesses, including cardiovascular disease (CVD) and neurodegenerative disorders (NDDs). GM influences host physiology by metabolizing dietary factors and host-derived substrates, thereby producing active molecules that trigger responses at local and systemic levels. The inflammatory process is characterized by a rapid \u201conset phase\u201d followed by a \u201cresolution phase\u201d, which is essential to curtail inflammation and restore tissue homeostasis. Unique individual and environmental conditions may alter the GM equilibrium as well as impair the \u201cresolution phase\u201d leading to GM dysbiosis and chronic low-grade inflammatory conditions, which eventually promote the development of common\/widespread human pathologies, such as inflammatory bowel and autoimmune diseases, cancer, CVD, and NDDs. This review describes the different components of the gastrointestinal tract, namely the enteroendocrine and enteric nervous systems, and the GM. Secondly, it discusses the connections among unresolved and sterile inflammation, GM and human illnesses, namely CVD and NDDs. Finally, we emphasizes the limitations of current evidence and the need for further research to fill the gap in establishing the causal link between the GM and the pathogenesis of both CVD and NDDs.<\/jats:p>","DOI":"10.31083\/fbl47174","type":"journal-article","created":{"date-parts":[[2026,5,30]],"date-time":"2026-05-30T07:25:36Z","timestamp":1780125936000},"source":"Crossref","is-referenced-by-count":2,"title":["The Microbiome Epoch: Cracking the Cardiovascular-Neurodegenerative Disorder Code"],"prefix":"10.31083","volume":"31","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5699-0918","authenticated-orcid":true,"given":"Cinzia","family":"Parolini","sequence":"first","affiliation":[{"name":"Department of Pharmacological and Biomolecular Sciences, Rodolfo Paoletti, Universit\u00e0 degli Studi di Milano, 20133 Milano, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6797-9343","authenticated-orcid":true,"given":"Amedeo","family":"Amedei","sequence":"additional","affiliation":[{"name":"Department of Clinical and Experimental Medicine, University of Florence, 50134 Florence, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"16242","published-online":{"date-parts":[[2026,5,22]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","unstructured":"Lloyd-Price J, Mahurkar A, Rahnavard G, Crabtree J, Orvis J, Hall AB, et al. Strains, functions and dynamics in the expanded Human Microbiome Project. Nature. 2017; 550: 61\u201366.","DOI":"10.1038\/nature23889"},{"key":"ref2","doi-asserted-by":"publisher","unstructured":"Parolini C. Effects of Fish n-3 PUFAs on Intestinal Microbiota and Immune System. Marine Drugs. 2019; 17: 374.","DOI":"10.3390\/md17060374"},{"key":"ref3","doi-asserted-by":"publisher","unstructured":"Zach M, Greslehner GP. Understanding immunity: an alternative framework beyond defense and strength. Biology & Philosophy. 2023; 38: 7.","DOI":"10.1007\/s10539-023-09893-2"},{"key":"ref4","doi-asserted-by":"publisher","unstructured":"Boem F, Lamminp\u00e4\u00e4 I, Amedei A. Updating the Discontinuity Theory to the Extended Immunity: The Symmunobiome Concept. European Journal of Immunology. 2025; 55: e202451528.","DOI":"10.1002\/eji.202451528"},{"key":"ref5","doi-asserted-by":"publisher","unstructured":"Calder PC, Albers R, Antoine JM, Blum S, Bourdet-Sicard R, Ferns GA, et al. Inflammatory disease processes and interactions with nutrition. The British Journal of Nutrition. 2009; 101: S1\u2013S45.","DOI":"10.1017\/S0007114509377867"},{"key":"ref6","doi-asserted-by":"publisher","unstructured":"Netea MG, Balkwill F, Chonchol M, Cominelli F, Donath MY, Giamarellos-Bourboulis EJ, et al. A guiding map for inflammation. Nature Immunology. 2017; 18: 826\u2013831.","DOI":"10.1038\/ni.3790"},{"key":"ref7","doi-asserted-by":"publisher","unstructured":"Sot\u00e1k M, Clark M, Suur BE, B\u00f6rgeson E. Inflammation and resolution in obesity. Nature Reviews. Endocrinology. 2025; 21: 45\u201361.","DOI":"10.1038\/s41574-024-01047-y"},{"key":"ref8","doi-asserted-by":"publisher","unstructured":"Larsen GL, Henson PM. Mediators of inflammation. Annual Review of Immunology. 1983; 1: 335\u2013359.","DOI":"10.1146\/annurev.iy.01.040183.002003"},{"key":"ref9","doi-asserted-by":"publisher","unstructured":"Serhan CN. Treating inflammation and infection in the 21st century: new hints from decoding resolution mediators and mechanisms. FASEB Journal. 2017; 31: 1273\u20131288.","DOI":"10.1096\/fj.201601222R"},{"key":"ref10","doi-asserted-by":"publisher","unstructured":"Serhan CN. Pro-resolving lipid mediators are leads for resolution physiology. Nature. 2014; 510: 92\u2013101.","DOI":"10.1038\/nature13479"},{"key":"ref11","doi-asserted-by":"publisher","unstructured":"Parolini C. Marine n-3 polyunsaturated fatty acids: Efficacy on inflammatory-based disorders. Life Sciences. 2020; 263: 118591.","DOI":"10.1016\/j.lfs.2020.118591"},{"key":"ref12","doi-asserted-by":"publisher","unstructured":"Fullerton JN, Gilroy DW. Resolution of inflammation: a new therapeutic frontier. Nature Reviews. Drug Discovery. 2016; 15: 551\u2013567.","DOI":"10.1038\/nrd.2016.39"},{"key":"ref13","doi-asserted-by":"publisher","unstructured":"Furman D, Campisi J, Verdin E, Carrera-Bastos P, Targ S, Franceschi C, et al. Chronic inflammation in the etiology of disease across the life span. Nature Medicine. 2019; 25: 1822\u20131832.","DOI":"10.1038\/s41591-019-0675-0"},{"key":"ref14","doi-asserted-by":"publisher","unstructured":"Iban-Arias R, Portela ASD, Masieri S, Radu A, Yang EJ, Chen LC, et al. Role of acute exposure to environmental stressors in the gut-brain-periphery axis in the presence of cognitive resilience. Biochimica et Biophysica Acta. Molecular Basis of Disease. 2025; 1871: 167760.","DOI":"10.1016\/j.bbadis.2025.167760"},{"key":"ref15","doi-asserted-by":"publisher","unstructured":"Varela ML, Mogildea M, Moreno I, Lopes A. Acute Inflammation and Metabolism. Inflammation. 2018; 41: 1115\u20131127.","DOI":"10.1007\/s10753-018-0739-1"},{"key":"ref16","doi-asserted-by":"publisher","unstructured":"Solier S, M\u00fcller S, Ca\u00f1eque T, Versini A, Mansart A, Sindikubwabo F, et al. A druggable copper-signalling pathway that drives inflammation. Nature. 2023; 617: 386\u2013394.","DOI":"10.1038\/s41586-023-06017-4"},{"key":"ref17","doi-asserted-by":"publisher","unstructured":"Fahim MA, Yao Y, Tipparaju SM, Xuan W. The heart-brain crosstalk in age related cardiovascular and neurodegenerative diseases. Fluids and Barriers of the CNS. 2025; 22: 89.","DOI":"10.1186\/s12987-025-00700-6"},{"key":"ref18","doi-asserted-by":"publisher","unstructured":"Sanna S, van Zuydam NR, Mahajan A, Kurilshikov A, Vich Vila A, V\u00f5sa U, et al. Causal relationships among the gut microbiome, short-chain fatty acids and metabolic diseases. Nature Genetics. 2019; 51: 600\u2013605.","DOI":"10.1038\/s41588-019-0350-x"},{"key":"ref19","doi-asserted-by":"publisher","unstructured":"Odenwald MA, Turner JR. The intestinal epithelial barrier: a therapeutic target? Nature Reviews. Gastroenterology & Hepatology. 2017; 14: 9\u201321.","DOI":"10.1038\/nrgastro.2016.169"},{"key":"ref20","doi-asserted-by":"publisher","unstructured":"Atanga R, Singh V, In JG. Intestinal Enteroendocrine Cells: Present and Future Druggable Targets. International Journal of Molecular Sciences. 2023; 24: 8836.","DOI":"10.3390\/ijms24108836"},{"key":"ref21","doi-asserted-by":"publisher","unstructured":"Rao M, Gershon MD. The bowel and beyond: the enteric nervous system in neurological disorders. Nature Reviews. Gastroenterology & Hepatology. 2016; 13: 517\u2013528.","DOI":"10.1038\/nrgastro.2016.107"},{"key":"ref22","doi-asserted-by":"publisher","unstructured":"France MM, Turner JR. The mucosal barrier at a glance. Journal of Cell Science. 2017; 130: 307\u2013314.","DOI":"10.1242\/jcs.193482"},{"key":"ref23","doi-asserted-by":"publisher","unstructured":"Sovran B, Hugenholtz F, Elderman M, Van Beek AA, Graversen K, Huijskes M, et al. Age-associated Impairment of the Mucus Barrier Function is Associated with Profound Changes in Microbiota and Immunity. Scientific Reports. 2019; 9: 1437.","DOI":"10.1038\/s41598-018-35228-3"},{"key":"ref24","doi-asserted-by":"publisher","unstructured":"Clark RI, Salazar A, Yamada R, Fitz-Gibbon S, Morselli M, Alcaraz J, et al. Distinct Shifts in Microbiota Composition during Drosophila Aging Impair Intestinal Function and Drive Mortality. Cell Reports. 2015; 12: 1656\u20131667.","DOI":"10.1016\/j.celrep.2015.08.004"},{"key":"ref25","doi-asserted-by":"publisher","unstructured":"Nyavor Y, Estill R, Edwards H, Ogden H, Heideman K, Starks K, et al. Intestinal nerve cell injury occurs prior to insulin resistance in female mice ingesting a high-fat diet. Cell and Tissue Research. 2019; 376: 325\u2013340.","DOI":"10.1007\/s00441-019-03002-0"},{"key":"ref26","doi-asserted-by":"publisher","unstructured":"Forsyth CB, Shannon KM, Kordower JH, Voigt RM, Shaikh M, Jaglin JA, et al. Increased intestinal permeability correlates with sigmoid mucosa alpha-synuclein staining and endotoxin exposure markers in early Parkinson\u2019s disease. PLoS ONE. 2011; 6: e28032.","DOI":"10.1371\/journal.pone.0028032"},{"key":"ref27","doi-asserted-by":"publisher","unstructured":"Schwiertz A, Spiegel J, Dillmann U, Grundmann D, B\u00fcrmann J, Fa\u00dfbender K, et al. Fecal markers of intestinal inflammation and intestinal permeability are elevated in Parkinson\u2019s disease. Parkinsonism & Related Disorders. 2018; 50: 104\u2013107.","DOI":"10.1016\/j.parkreldis.2018.02.022"},{"key":"ref28","doi-asserted-by":"publisher","unstructured":"Sharkey KA. Emerging roles for enteric glia in gastrointestinal disorders. The Journal of Clinical Investigation. 2015; 125: 918\u2013925.","DOI":"10.1172\/JCI76303"},{"key":"ref29","doi-asserted-by":"publisher","unstructured":"Moran GW, Leslie FC, Levison SE, Worthington J, McLaughlin JT. Enteroendocrine cells: neglected players in gastrointestinal disorders? Therapeutic Advances in Gastroenterology. 2008; 1: 51\u201360.","DOI":"10.1177\/1756283X08093943"},{"key":"ref30","doi-asserted-by":"publisher","unstructured":"Holst JJ. Enteroendocrine secretion of gut hormones in diabetes, obesity and after bariatric surgery. Current Opinion in Pharmacology. 2013; 13: 983\u2013988.","DOI":"10.1016\/j.coph.2013.09.014"},{"key":"ref31","doi-asserted-by":"publisher","unstructured":"Boh\u00f3rquez DV, Samsa LA, Roholt A, Medicetty S, Chandra R, Liddle RA. An enteroendocrine cell-enteric glia connection revealed by 3D electron microscopy. PLoS ONE. 2014; 9: e89881.","DOI":"10.1371\/journal.pone.0089881"},{"key":"ref32","doi-asserted-by":"publisher","unstructured":"Kaelberer MM, Buchanan KL, Klein ME, Barth BB, Montoya MM, Shen X, et al. A gut-brain neural circuit for nutrient sensory transduction. Science. 2018; 361: eaat5236.","DOI":"10.1126\/science.aat5236"},{"key":"ref33","doi-asserted-by":"publisher","unstructured":"Psichas A, Reimann F, Gribble FM. Gut chemosensing mechanisms. The Journal of Clinical Investigation. 2015; 125: 908\u2013917.","DOI":"10.1172\/JCI76309"},{"key":"ref34","doi-asserted-by":"publisher","unstructured":"Chaikomin R, Wu KL, Doran S, Meyer JH, Jones KL, Feinle-Bisset C, et al. Effects of mid-jejunal compared to duodenal glucose infusion on peptide hormone release and appetite in healthy men. Regulatory Peptides. 2008; 150: 38\u201342.","DOI":"10.1016\/j.regpep.2008.02.006"},{"key":"ref35","doi-asserted-by":"publisher","unstructured":"Ritzel U, Fromme A, Ottleben M, Leonhardt U, Ramadori G. Release of glucagon-like peptide-1 (GLP-1) by carbohydrates in the perfused rat ileum. Acta Diabetologica. 1997; 34: 18\u201321.","DOI":"10.1007\/s005920050059"},{"key":"ref36","doi-asserted-by":"publisher","unstructured":"Matsumura K, Miki T, Jhomori T, Gonoi T, Seino S. Possible role of PEPT1 in gastrointestinal hormone secretion. Biochemical and Biophysical Research Communications. 2005; 336: 1028\u20131032.","DOI":"10.1016\/j.bbrc.2005.08.259"},{"key":"ref37","doi-asserted-by":"publisher","unstructured":"Mace OJ, Schindler M, Patel S. The regulation of K- and L-cell activity by GLUT2 and the calcium-sensing receptor CasR in rat small intestine. The Journal of Physiology. 2012; 590: 2917\u20132936.","DOI":"10.1113\/jphysiol.2011.223800"},{"key":"ref38","doi-asserted-by":"publisher","unstructured":"Lauffer LM, Iakoubov R, Brubaker PL. GPR119 is essential for oleoylethanolamide-induced glucagon-like peptide-1 secretion from the intestinal enteroendocrine L-cell. Diabetes. 2009; 58: 1058\u20131066.","DOI":"10.2337\/db08-1237"},{"key":"ref39","doi-asserted-by":"publisher","unstructured":"Edfalk S, Steneberg P, Edlund H. Gpr40 is expressed in enteroendocrine cells and mediates free fatty acid stimulation of incretin secretion. Diabetes. 2008; 57: 2280\u20132287.","DOI":"10.2337\/db08-0307"},{"key":"ref40","doi-asserted-by":"publisher","unstructured":"Hara T, Hirasawa A, Ichimura A, Kimura I, Tsujimoto G. Free fatty acid receptors FFAR1 and GPR120 as novel therapeutic targets for metabolic disorders. Journal of Pharmaceutical Sciences. 2011; 100: 3594\u20133601.","DOI":"10.1002\/jps.22639"},{"key":"ref41","doi-asserted-by":"publisher","unstructured":"Bogunovic M, Dav\u00e9 SH, Tilstra JS, Chang DTW, Harpaz N, Xiong H, et al. Enteroendocrine cells express functional Toll-like receptors. American Journal of Physiology. Gastrointestinal and Liver Physiology. 2007; 292: G1770\u2013G1783.","DOI":"10.1152\/ajpgi.00249.2006"},{"key":"ref42","doi-asserted-by":"publisher","unstructured":"Selleri S, Palazzo M, Deola S, Wang E, Balsari A, Marincola FM, et al. Induction of pro-inflammatory programs in enteroendocrine cells by the Toll-like receptor agonists flagellin and bacterial LPS. International Immunology. 2008; 20: 961\u2013970.","DOI":"10.1093\/intimm\/dxn055"},{"key":"ref43","doi-asserted-by":"publisher","unstructured":"Cox HM. Peptide YY: a neuroendocrine neighbor of note. Peptides. 2007; 28: 345\u2013351.","DOI":"10.1016\/j.peptides.2006.07.023"},{"key":"ref44","doi-asserted-by":"publisher","unstructured":"Wedel T, Roblick U, Gleiss J, Schiedeck T, Bruch HP, K\u00fchnel W, et al. Organization of the enteric nervous system in the human colon demonstrated by wholemount immunohistochemistry with special reference to the submucous plexus. Annals of Anatomy = Anatomischer Anzeiger. 1999; 181: 327\u2013337.","DOI":"10.1016\/S0940-9602(99)80122-8"},{"key":"ref45","doi-asserted-by":"publisher","unstructured":"Furness JB, Callaghan BP, Rivera LR, Cho HJ. The enteric nervous system and gastrointestinal innervation: integrated local and central control. Advances in Experimental Medicine and Biology. 2014; 817: 39\u201371.","DOI":"10.1007\/978-1-4939-0897-4_3"},{"key":"ref46","doi-asserted-by":"publisher","unstructured":"Grubi\u0161i\u0107 V, Gulbransen BD. Enteric glia: the most alimentary of all glia. The Journal of Physiology. 2017; 595: 557\u2013570.","DOI":"10.1113\/JP271021"},{"key":"ref47","doi-asserted-by":"publisher","unstructured":"L\u00f3pez-Redondo F, Lees GM, Pertwee RG. Effects of cannabinoid receptor ligands on electrophysiological properties of myenteric neurones of the guinea-pig ileum. British Journal of Pharmacology. 1997; 122: 330\u2013334.","DOI":"10.1038\/sj.bjp.0701393"},{"key":"ref48","doi-asserted-by":"publisher","unstructured":"Coutts AA, Irving AJ, Mackie K, Pertwee RG, Anavi-Goffer S. Localisation of cannabinoid CB(1) receptor immunoreactivity in the guinea pig and rat myenteric plexus. The Journal of Comparative Neurology. 2002; 448: 410\u2013422.","DOI":"10.1002\/cne.10270"},{"key":"ref49","doi-asserted-by":"publisher","unstructured":"Forsythe P, Bienenstock J, Kunze WA. Vagal pathways for microbiome-brain-gut axis communication. Advances in Experimental Medicine and Biology. 2014; 817: 115\u2013133.","DOI":"10.1007\/978-1-4939-0897-4_5"},{"key":"ref50","doi-asserted-by":"publisher","unstructured":"Mayer EA. Gut feelings: the emerging biology of gut-brain communication. Nature Reviews. Neuroscience. 2011; 12: 453\u2013466.","DOI":"10.1038\/nrn3071"},{"key":"ref51","doi-asserted-by":"publisher","unstructured":"Zhuang C, Chen Q, Dou X, Zhang Y, Jin W, Lu X, et al. Pathogenic mechanisms of cerebral ischemia and potential gut-brain axis-oriented therapeutic strategies. Phytomedicine: International Journal of Phytotherapy and Phytopharmacology. 2025; 148: 157264.","DOI":"10.1016\/j.phymed.2025.157264"},{"key":"ref52","doi-asserted-by":"publisher","unstructured":"Cryan JF, Dinan TG. Mind-altering microorganisms: the impact of the gut microbiota on brain and behaviour. Nature Reviews. Neuroscience. 2012; 13: 701\u2013712.","DOI":"10.1038\/nrn3346"},{"key":"ref53","doi-asserted-by":"publisher","unstructured":"De Giorgio R, Bianco F, Latorre R, Caio G, Clavenzani P, Bonora E. Enteric neuropathies: Yesterday, Today and Tomorrow. Advances in Experimental Medicine and Biology. 2016; 891: 123\u2013133.","DOI":"10.1007\/978-3-319-27592-5_12"},{"key":"ref54","doi-asserted-by":"publisher","unstructured":"De Palma G, Collins SM, Bercik P, Verdu EF. The microbiota-gut-brain axis in gastrointestinal disorders: stressed bugs, stressed brain or both? The Journal of Physiology. 2014; 592: 2989\u20132997.","DOI":"10.1113\/jphysiol.2014.273995"},{"key":"ref55","doi-asserted-by":"publisher","unstructured":"Niesler B, Kuerten S, Demir IE, Sch\u00e4fer KH. Disorders of the enteric nervous system - a holistic view. Nature Reviews. Gastroenterology & Hepatology. 2021; 18: 393\u2013410.","DOI":"10.1038\/s41575-020-00385-2"},{"key":"ref56","doi-asserted-by":"publisher","unstructured":"Tilg H, Moschen AR. Food, immunity, and the microbiome. Gastroenterology. 2015; 148: 1107\u20131119.","DOI":"10.1053\/j.gastro.2014.12.036"},{"key":"ref57","doi-asserted-by":"publisher","unstructured":"Chavakis T, Alexaki VI, Ferrante AW, Jr. Macrophage function in adipose tissue homeostasis and metabolic inflammation. Nature Immunology. 2023; 24: 757\u2013766.","DOI":"10.1038\/s41590-023-01479-0"},{"key":"ref58","doi-asserted-by":"publisher","unstructured":"Tang WHW, Hazen SL. The Gut Microbiome and Its Role in Cardiovascular Diseases. Circulation. 2017; 135: 1008\u20131010.","DOI":"10.1161\/CIRCULATIONAHA.116.024251"},{"key":"ref59","doi-asserted-by":"publisher","unstructured":"Lamminp\u00e4\u00e4 I, Amedei A, Parolini C. Effects of Marine-Derived Components on Cardiovascular Disease Risk Factors and Gut Microbiota Diversity. Marine Drugs. 2024; 22: 523.","DOI":"10.3390\/md22110523"},{"key":"ref60","doi-asserted-by":"publisher","unstructured":"Andersen CJ, Murphy KE, Fernandez ML. Impact of Obesity and Metabolic Syndrome on Immunity. Advances in Nutrition. 2016; 7: 66\u201375.","DOI":"10.3945\/an.115.010207"},{"key":"ref61","doi-asserted-by":"publisher","unstructured":"Kanneganti TD, Dixit VD. Immunological complications of obesity. Nature Immunology. 2012; 13: 707\u2013712.","DOI":"10.1038\/ni.2343"},{"key":"ref62","doi-asserted-by":"publisher","unstructured":"Luse MA, Schug WJ, Dunaway LS, Nyshadham S, Loeb SA, Carvalho A, et al. Nitrosation of CD36 Regulates Endothelial Function and Serum Lipids. Arteriosclerosis, Thrombosis, and Vascular Biology. 2025; 45: 1067\u20131086.","DOI":"10.1161\/ATVBAHA.124.321964"},{"key":"ref63","doi-asserted-by":"publisher","unstructured":"L\u00f3pez-Vicario C, Titos E, Walker ME, Alcaraz-Quiles J, Casulleras M, Dur\u00e1n-G\u00fcell M, et al. Leukocytes from obese individuals exhibit an impaired SPM signature. FASEB Journal. 2019; 33: 7072\u20137083.","DOI":"10.1096\/fj.201802587R"},{"key":"ref64","doi-asserted-by":"publisher","unstructured":"Pena Calderin E, Zheng JJ, Boyd NL, Lynch W, Sansbury BE, Spite M, et al. Exercise-Stimulated Resolvin Biosynthesis in the Adipose Tissue Is Abrogated by High-Fat Diet-Induced Adrenergic Deficiency. Arteriosclerosis, Thrombosis, and Vascular Biology. 2025; 45: 1090\u20131110.","DOI":"10.1161\/ATVBAHA.124.322234"},{"key":"ref65","doi-asserted-by":"publisher","unstructured":"Kosteli A, Sugaru E, Haemmerle G, Martin JF, Lei J, Zechner R, et al. Weight loss and lipolysis promote a dynamic immune response in murine adipose tissue. The Journal of Clinical Investigation. 2010; 120: 3466\u20133479.","DOI":"10.1172\/JCI42845"},{"key":"ref66","doi-asserted-by":"publisher","unstructured":"B\u00e4ck M, Hansson GK. Omega-3 fatty acids, cardiovascular risk, and the resolution of inflammation. FASEB Journal: Official Publication of the Federation of American Societies for Experimental Biology. 2019; 33: 1536\u20131539.","DOI":"10.1096\/fj.201802445R"},{"key":"ref67","doi-asserted-by":"publisher","unstructured":"Loukil I, Mutch DM, Plourde M. Genetic association between FADS and ELOVL polymorphisms and the circulating levels of EPA\/DHA in humans: a scoping review. Genes & Nutrition. 2024; 19: 11.","DOI":"10.1186\/s12263-024-00747-4"},{"key":"ref68","doi-asserted-by":"publisher","unstructured":"Schneeberger M, Everard A, G\u00f3mez-Valad\u00e9s AG, Matamoros S, Ram\u00edrez S, Delzenne NM, et al. Akkermansia muciniphila inversely correlates with the onset of inflammation, altered adipose tissue metabolism and metabolic disorders during obesity in mice. Scientific Reports. 2015; 5: 16643.","DOI":"10.1038\/srep16643"},{"key":"ref69","doi-asserted-by":"publisher","unstructured":"Li J, Lin S, Vanhoutte PM, Woo CW, Xu A. Akkermansia Muciniphila Protects Against Atherosclerosis by Preventing Metabolic Endotoxemia-Induced Inflammation in Apoe-\/- Mice. Circulation. 2016; 133: 2434\u20132446.","DOI":"10.1161\/CIRCULATIONAHA.115.019645"},{"key":"ref70","doi-asserted-by":"publisher","unstructured":"Ellekilde M, Krych L, Hansen CHF, Hufeldt MR, Dahl K, Hansen LH, et al. Characterization of the gut microbiota in leptin deficient obese mice - Correlation to inflammatory and diabetic parameters. Research in Veterinary Science. 2014; 96: 241\u2013250.","DOI":"10.1016\/j.rvsc.2014.01.007"},{"key":"ref71","doi-asserted-by":"publisher","unstructured":"Derrien M, Belzer C, de Vos WM. Akkermansia muciniphila and its role in regulating host functions. Microbial Pathogenesis. 2017; 106: 171\u2013181.","DOI":"10.1016\/j.micpath.2016.02.005"},{"key":"ref72","doi-asserted-by":"publisher","unstructured":"Everard A, Belzer C, Geurts L, Ouwerkerk JP, Druart C, Bindels LB, et al. Cross-talk between Akkermansia muciniphila and intestinal epithelium controls diet-induced obesity. Proceedings of the National Academy of Sciences of the United States of America. 2013; 110: 9066\u20139071.","DOI":"10.1073\/pnas.1219451110"},{"key":"ref73","doi-asserted-by":"publisher","unstructured":"Shin NR, Lee JC, Lee HY, Kim MS, Whon TW, Lee MS, et al. An increase in the Akkermansia spp. population induced by metformin treatment improves glucose homeostasis in diet-induced obese mice. Gut. 2014; 63: 727\u2013735.","DOI":"10.1136\/gutjnl-2012-303839"},{"key":"ref74","doi-asserted-by":"publisher","unstructured":"Cani PD. Human gut microbiome: hopes, threats and promises. Gut. 2018; 67: 1716\u20131725.","DOI":"10.1136\/gutjnl-2018-316723"},{"key":"ref75","doi-asserted-by":"publisher","unstructured":"Tett A, Pasolli E, Masetti G, Ercolini D, Segata N. Prevotella diversity, niches and interactions with the human host. Nature Reviews. Microbiology. 2021; 19: 585\u2013599.","DOI":"10.1038\/s41579-021-00559-y"},{"key":"ref76","doi-asserted-by":"publisher","unstructured":"Blacher E, Levy M, Tatirovsky E, Elinav E. Microbiome-Modulated Metabolites at the Interface of Host Immunity. Journal of Immunology. 2017; 198: 572\u2013580.","DOI":"10.4049\/jimmunol.1601247"},{"key":"ref77","doi-asserted-by":"publisher","unstructured":"Arpaia N, Campbell C, Fan X, Dikiy S, van der Veeken J, deRoos P, et al. Metabolites produced by commensal bacteria promote peripheral regulatory T-cell generation. Nature. 2013; 504: 451\u2013455.","DOI":"10.1038\/nature12726"},{"key":"ref78","doi-asserted-by":"publisher","unstructured":"Lewis K, Lutgendorff F, Phan V, S\u00f6derholm JD, Sherman PM, McKay DM. Enhanced translocation of bacteria across metabolically stressed epithelia is reduced by butyrate. Inflammatory Bowel Diseases. 2010; 16: 1138\u20131148.","DOI":"10.1002\/ibd.21177"},{"key":"ref79","doi-asserted-by":"publisher","unstructured":"Barcelo A, Claustre J, Moro F, Chayvialle JA, Cuber JC, Plaisanci\u00e9 P. Mucin secretion is modulated by luminal factors in the isolated vascularly perfused rat colon. Gut. 2000; 46: 218\u2013224.","DOI":"10.1136\/gut.46.2.218"},{"key":"ref80","doi-asserted-by":"publisher","unstructured":"Cherbut C, Ferrier L, Roz\u00e9 C, Anini Y, Blotti\u00e8re H, Lecannu G, et al. Short-chain fatty acids modify colonic motility through nerves and polypeptide YY release in the rat. The American Journal of Physiology. 1998; 275: G1415\u2013G1422.","DOI":"10.1152\/ajpgi.1998.275.6.G1415"},{"key":"ref81","doi-asserted-by":"publisher","unstructured":"Brown JM, Hazen SL. Microbial modulation of cardiovascular disease. Nature Reviews. Microbiology. 2018; 16: 171\u2013181.","DOI":"10.1038\/nrmicro.2017.149"},{"key":"ref82","doi-asserted-by":"publisher","unstructured":"G\u00e9lineau A, Marcelin G, Ouhachi M, Dussaud S, Voland L, Manuel R, et al. Fructooligosaccharides benefits on glucose homeostasis upon high-fat diet feeding require type 2 conventional dendritic cells. Nature Communications. 2024; 15: 5413.","DOI":"10.1038\/s41467-024-49820-x"},{"key":"ref83","doi-asserted-by":"publisher","unstructured":"Mann ER, Lam YK, Uhlig HH. Short-chain fatty acids: linking diet, the microbiome and immunity. Nature Reviews. Immunology. 2024; 24: 577\u2013595.","DOI":"10.1038\/s41577-024-01014-8"},{"key":"ref84","doi-asserted-by":"publisher","unstructured":"Brown AJ, Goldsworthy SM, Barnes AA, Eilert MM, Tcheang L, Daniels D, et al. The Orphan G protein-coupled receptors GPR41 and GPR43 are activated by propionate and other short chain carboxylic acids. The Journal of Biological Chemistry. 2003; 278: 11312\u201311319.","DOI":"10.1074\/jbc.M211609200"},{"key":"ref85","doi-asserted-by":"publisher","unstructured":"Thangaraju M, Cresci GA, Liu K, Ananth S, Gnanaprakasam JP, Browning DD, et al. GPR109A is a G-protein-coupled receptor for the bacterial fermentation product butyrate and functions as a tumor suppressor in colon. Cancer Research. 2009; 69: 2826\u20132832.","DOI":"10.1158\/0008-5472.CAN-08-4466"},{"key":"ref86","doi-asserted-by":"publisher","unstructured":"Pluznick JL, Protzko RJ, Gevorgyan H, Peterlin Z, Sipos A, Han J, et al. Olfactory receptor responding to gut microbiota-derived signals plays a role in renin secretion and blood pressure regulation. Proceedings of the National Academy of Sciences of the United States of America. 2013; 110: 4410\u20134415.","DOI":"10.1073\/pnas.1215927110"},{"key":"ref87","doi-asserted-by":"publisher","unstructured":"Kim CH, Park J, Kim M. Gut microbiota-derived short-chain Fatty acids, T cells, and inflammation. Immune Network. 2014; 14: 277\u2013288.","DOI":"10.4110\/in.2014.14.6.277"},{"key":"ref88","doi-asserted-by":"publisher","unstructured":"Peng L, He Z, Chen W, Holzman IR, Lin J. Effects of butyrate on intestinal barrier function in a Caco-2 cell monolayer model of intestinal barrier. Pediatric Research. 2007; 61: 37\u201341.","DOI":"10.1203\/01.pdr.0000250014.92242.f3"},{"key":"ref89","doi-asserted-by":"publisher","unstructured":"Schwiertz A, Taras D, Sch\u00e4fer K, Beijer S, Bos NA, Donus C, et al. Microbiota and SCFA in lean and overweight healthy subjects. Obesity (Silver Spring, Md.). 2010; 18: 190\u2013195.","DOI":"10.1038\/oby.2009.167"},{"key":"ref90","doi-asserted-by":"publisher","unstructured":"Hangul C, Ozyurt OK, Baldi S, Colak D, Tokta O, Pekcan T, et al. Gut Microbiota and Short-Chain Fatty Acid Profiles in Facioscapulohumeral Dystrophy: Associations with Epigenetic Alterations. The Canadian Journal of Neurological Sciences. Le Journal Canadien des Sciences Neurologiques. 2025.  (online ahead of print)","DOI":"10.1017\/cjn.2025.10388"},{"key":"ref91","doi-asserted-by":"publisher","unstructured":"Bellando-Randone S, Russo E, Di Gloria L, Lepri G, Baldi S, Fioretto BS, et al. Gut microbiota in very early systemic sclerosis: the first case-control taxonomic and functional characterisation highlighting an altered butyric acid profile. RMD Open. 2024; 10: e004647.","DOI":"10.1136\/rmdopen-2024-004647"},{"key":"ref92","doi-asserted-by":"publisher","unstructured":"Baldi S, Menicatti M, Nannini G, Niccolai E, Russo E, Ricci F, et al. Free Fatty Acids Signature in Human Intestinal Disorders: Significant Association between Butyric Acid and Celiac Disease. Nutrients. 2021; 13: 742.","DOI":"10.3390\/nu13030742"},{"key":"ref93","doi-asserted-by":"publisher","unstructured":"Niccolai E, Pedone M, Martinelli I, Nannini G, Baldi S, Simonini C, et al. Amyotrophic lateral sclerosis stratification: unveiling patterns with virome, inflammation, and metabolism molecules. Journal of Neurology. 2024; 271: 4310\u20134325.","DOI":"10.1007\/s00415-024-12348-7"},{"key":"ref94","doi-asserted-by":"publisher","unstructured":"Costantino-Jonapa LA, Aguilar-Villegas OR, Hern\u00e1ndez-Ruiz P, Escalona-Monta\u00f1o AR, Pallecchi M, Gonz\u00e1lez-Pacheco H, et al. The link between inflammatory\/ SCFA profiles and oral\/gut microbiome: an observational study in patients with ST-segment elevation myocardial infarction. Current Research in Microbial Sciences. 2025; 9: 100423.","DOI":"10.1016\/j.crmicr.2025.100423"},{"key":"ref95","doi-asserted-by":"publisher","unstructured":"Bennett BJ, de Aguiar Vallim TQ, Wang Z, Shih DM, Meng Y, Gregory J, et al. Trimethylamine-N-oxide, a metabolite associated with atherosclerosis, exhibits complex genetic and dietary regulation. Cell Metabolism. 2013; 17: 49\u201360.","DOI":"10.1016\/j.cmet.2012.12.011"},{"key":"ref96","doi-asserted-by":"publisher","unstructured":"Koeth RA, Wang Z, Levison BS, Buffa JA, Org E, Sheehy BT, et al. Intestinal microbiota metabolism of L-carnitine, a nutrient in red meat, promotes atherosclerosis. Nature Medicine. 2013; 19: 576\u2013585.","DOI":"10.1038\/nm.3145"},{"key":"ref97","doi-asserted-by":"publisher","unstructured":"Tang WHW, Wang Z, Levison BS, Koeth RA, Britt EB, Fu X, et al. Intestinal microbial metabolism of phosphatidylcholine and cardiovascular risk. The New England Journal of Medicine. 2013; 368: 1575\u20131584.","DOI":"10.1056\/NEJMoa1109400"},{"key":"ref98","doi-asserted-by":"publisher","unstructured":"Constantino-Jonapa LA, Espinoza-Palacios Y, Escalona-Monta\u00f1o AR, Hern\u00e1ndez-Ruiz P, Amezcua-Guerra LM, Amedei A, et al. Contribution of Trimethylamine N-Oxide (TMAO) to Chronic Inflammatory and Degenerative Diseases. Biomedicines. 2023; 11: 431.","DOI":"10.3390\/biomedicines11020431"},{"key":"ref99","doi-asserted-by":"publisher","unstructured":"Caradonna E, Abate F, Schiano E, Paparella F, Ferrara F, Vanoli E, et al. Trimethylamine-N-Oxide (TMAO) as a Rising-Star Metabolite: Implications for Human Health. Metabolites. 2025; 15: 220.","DOI":"10.3390\/metabo15040220"},{"key":"ref100","doi-asserted-by":"publisher","unstructured":"Ridlon JM, Kang DJ, Hylemon PB, Bajaj JS. Bile acids and the gut microbiome. Current Opinion in Gastroenterology. 2014; 30: 332\u2013338.","DOI":"10.1097\/MOG.0000000000000057"},{"key":"ref101","doi-asserted-by":"publisher","unstructured":"Begley M, Gahan CGM, Hill C. The interaction between bacteria and bile. FEMS Microbiology Reviews. 2005; 29: 625\u2013651.","DOI":"10.1016\/j.femsre.2004.09.003"},{"key":"ref102","doi-asserted-by":"publisher","unstructured":"Molinero N, Ruiz L, S\u00e1nchez B, Margolles A, Delgado S. Intestinal Bacteria Interplay With Bile and Cholesterol Metabolism: Implications on Host Physiology. Frontiers in Physiology. 2019; 10: 185.","DOI":"10.3389\/fphys.2019.00185"},{"key":"ref103","doi-asserted-by":"publisher","unstructured":"Joyce SA, MacSharry J, Casey PG, Kinsella M, Murphy EF, Shanahan F, et al. Regulation of host weight gain and lipid metabolism by bacterial bile acid modification in the gut. Proceedings of the National Academy of Sciences of the United States of America. 2014; 111: 7421\u20137426.","DOI":"10.1073\/pnas.1323599111"},{"key":"ref104","doi-asserted-by":"publisher","unstructured":"Jia W, Xie G, Jia W. Bile acid-microbiota crosstalk in gastrointestinal inflammation and carcinogenesis. Nature Reviews. Gastroenterology & Hepatology. 2018; 15: 111\u2013128.","DOI":"10.1038\/nrgastro.2017.119"},{"key":"ref105","doi-asserted-by":"publisher","unstructured":"Makishima M, Okamoto AY, Repa JJ, Tu H, Learned RM, Luk A, et al. Identification of a nuclear receptor for bile acids. Science. 1999; 284: 1362\u20131365.","DOI":"10.1126\/science.284.5418.1362"},{"key":"ref106","doi-asserted-by":"publisher","unstructured":"Makishima M, Lu TT, Xie W, Whitfield GK, Domoto H, Evans RM, et al. Vitamin D receptor as an intestinal bile acid sensor. Science. 2002; 296: 1313\u20131316.","DOI":"10.1126\/science.1070477"},{"key":"ref107","doi-asserted-by":"publisher","unstructured":"Lu S, Guo S, Hu F, Guo Y, Yan L, Ma W, et al. The Associations Between the Polymorphisms of Vitamin D Receptor and Coronary Artery Disease: A Systematic Review and Meta-Analysis. Medicine (Baltimore). 2016; 95: e3467.","DOI":"10.1097\/MD.0000000000003467"},{"key":"ref108","doi-asserted-by":"publisher","unstructured":"Szeto FL, Reardon CA, Yoon D, Wang Y, Wong KE, Chen Y, et al. Vitamin D receptor signaling inhibits atherosclerosis in mice. Molecular Endocrinology (Baltimore, Md.). 2012; 26: 1091\u20131101.","DOI":"10.1210\/me.2011-1329"},{"key":"ref109","doi-asserted-by":"publisher","unstructured":"Pols TWH, Nomura M, Harach T, Lo Sasso G, Oosterveer MH, Thomas C, et al. TGR5 activation inhibits atherosclerosis by reducing macrophage inflammation and lipid loading. Cell Metabolism. 2011; 14: 747\u2013757.","DOI":"10.1016\/j.cmet.2011.11.006"},{"key":"ref110","doi-asserted-by":"publisher","unstructured":"Staudinger JL, Goodwin B, Jones SA, Hawkins-Brown D, MacKenzie KI, LaTour A, et al. The nuclear receptor PXR is a lithocholic acid sensor that protects against liver toxicity. Proceedings of the National Academy of Sciences of the United States of America. 2001; 98: 3369\u20133374.","DOI":"10.1073\/pnas.051551698"},{"key":"ref111","doi-asserted-by":"publisher","unstructured":"Parolini C. Sepsis and high-density lipoproteins: Pathophysiology and potential new therapeutic targets. Biochimica et Biophysica Acta. Molecular Basis of Disease. 2025; 1871: 167761.","DOI":"10.1016\/j.bbadis.2025.167761"},{"key":"ref112","doi-asserted-by":"publisher","unstructured":"Schubring SR, Fleischer W, Lin JS, Haas HL, Sergeeva OA. The bile steroid chenodeoxycholate is a potent antagonist at NMDA and GABA(A) receptors. Neuroscience Letters. 2012; 506: 322\u2013326.","DOI":"10.1016\/j.neulet.2011.11.036"},{"key":"ref113","doi-asserted-by":"publisher","unstructured":"Quinn M, McMillin M, Galindo C, Frampton G, Pae HY, DeMorrow S. Bile acids permeabilize the blood brain barrier after bile duct ligation in rats via Rac1-dependent mechanisms. Digestive and Liver Disease. 2014; 46: 527\u2013534.","DOI":"10.1016\/j.dld.2014.01.159"},{"key":"ref114","doi-asserted-by":"publisher","unstructured":"Iusuf D, van de Steeg E, Schinkel AH. Functions of OATP1A and 1B transporters in vivo: insights from mouse models. Trends in Pharmacological Sciences. 2012; 33: 100\u2013108.","DOI":"10.1016\/j.tips.2011.10.005"},{"key":"ref115","doi-asserted-by":"publisher","unstructured":"McMillin M, Frampton G, Quinn M, Ashfaq S, de los Santos M, 3rd, Grant S, et al. Bile Acid Signaling Is Involved in the Neurological Decline in a Murine Model of Acute Liver Failure. The American Journal of Pathology. 2016; 186: 312\u2013323.","DOI":"10.1016\/j.ajpath.2015.10.005"},{"key":"ref116","doi-asserted-by":"publisher","unstructured":"Choudhuri S, Cherrington NJ, Li N, Klaassen CD. Constitutive expression of various xenobiotic and endobiotic transporter mRNAs in the choroid plexus of rats. Drug Metabolism and Disposition: the Biological Fate of Chemicals. 2003; 31: 1337\u20131345.","DOI":"10.1124\/dmd.31.11.1337"},{"key":"ref117","doi-asserted-by":"publisher","unstructured":"Sayin SI, Wahlstr\u00f6m A, Felin J, J\u00e4ntti S, Marschall HU, Bamberg K, et al. Gut microbiota regulates bile acid metabolism by reducing the levels of tauro-beta-muricholic acid, a naturally occurring FXR antagonist. Cell Metabolism. 2013; 17: 225\u2013235.","DOI":"10.1016\/j.cmet.2013.01.003"},{"key":"ref118","doi-asserted-by":"publisher","unstructured":"Alkhalaf LM, Ryan KS. Biosynthetic manipulation of tryptophan in bacteria: pathways and mechanisms. Chemistry & Biology. 2015; 22: 317\u2013328.","DOI":"10.1016\/j.chembiol.2015.02.005"},{"key":"ref119","doi-asserted-by":"publisher","unstructured":"Lamas B, Natividad JM, Sokol H. Aryl hydrocarbon receptor and intestinal immunity. Mucosal Immunology. 2018; 11: 1024\u20131038.","DOI":"10.1038\/s41385-018-0019-2"},{"key":"ref120","doi-asserted-by":"publisher","unstructured":"Parolini C. Pathophysiology of bone remodelling cycle: Role of immune system and lipids. Biochemical Pharmacology. 2025; 235: 116844.","DOI":"10.1016\/j.bcp.2025.116844"},{"key":"ref121","doi-asserted-by":"publisher","unstructured":"Zelante T, Iannitti RG, Cunha C, De Luca A, Giovannini G, Pieraccini G, et al. Tryptophan catabolites from microbiota engage aryl hydrocarbon receptor and balance mucosal reactivity via interleukin-22. Immunity. 2013; 39: 372\u2013385.","DOI":"10.1016\/j.immuni.2013.08.003"},{"key":"ref122","doi-asserted-by":"publisher","unstructured":"Kennedy PJ, Cryan JF, Dinan TG, Clarke G. Kynurenine pathway metabolism and the microbiota-gut-brain axis. Neuropharmacology. 2017; 112: 399\u2013412.","DOI":"10.1016\/j.neuropharm.2016.07.002"},{"key":"ref123","doi-asserted-by":"publisher","unstructured":"Spencer NJ, Keating DJ. Role of 5-HT in the enteric nervous system and enteroendocrine cells. British Journal of Pharmacology. 2025; 182: 471\u2013483.","DOI":"10.1111\/bph.15930"},{"key":"ref124","doi-asserted-by":"publisher","unstructured":"Reigstad CS, Salmonson CE, Rainey JF, 3rd, Szurszewski JH, Linden DR, Sonnenburg JL, et al. Gut microbes promote colonic serotonin production through an effect of short-chain fatty acids on enterochromaffin cells. FASEB Journal. 2015; 29: 1395\u20131403.","DOI":"10.1096\/fj.14-259598"},{"key":"ref125","doi-asserted-by":"publisher","unstructured":"Yano JM, Yu K, Donaldson GP, Shastri GG, Ann P, Ma L, et al. Indigenous bacteria from the gut microbiota regulate host serotonin biosynthesis. Cell. 2015; 161: 264\u2013276.","DOI":"10.1016\/j.cell.2015.02.047"},{"key":"ref126","doi-asserted-by":"publisher","unstructured":"Walker RL, Vlamakis H, Lee JWJ, Besse LA, Xanthakis V, Vasan RS, et al. Population study of the gut microbiome: associations with diet, lifestyle, and cardiometabolic disease. Genome Medicine. 2021; 13: 188.","DOI":"10.1186\/s13073-021-01007-5"},{"key":"ref127","doi-asserted-by":"publisher","unstructured":"Du F, Wang L, Qian W, Liu S. Loss of enteric neurons accompanied by decreased expression of GDNF and PI3K\/Akt pathway in diabetic rats. Neurogastroenterology and Motility. 2009; 21: 1229\u2013e114.","DOI":"10.1111\/j.1365-2982.2009.01379.x"},{"key":"ref128","doi-asserted-by":"publisher","unstructured":"Pasricha PJ, Pehlivanov ND, Gomez G, Vittal H, Lurken MS, Farrugia G. Changes in the gastric enteric nervous system and muscle: a case report on two patients with diabetic gastroparesis. BMC Gastroenterology. 2008; 8: 21.","DOI":"10.1186\/1471-230X-8-21"},{"key":"ref129","doi-asserted-by":"publisher","unstructured":"Meldgaard T, Olesen SS, Farmer AD, Krogh K, Wendel AA, Brock B, et al. Diabetic Enteropathy: From Molecule to Mechanism-Based Treatment. Journal of Diabetes Research. 2018; 2018: 3827301.","DOI":"10.1155\/2018\/3827301"},{"key":"ref130","doi-asserted-by":"publisher","unstructured":"Hara H, Haga S, Aoyama Y, Kiriyama S. Short-chain fatty acids suppress cholesterol synthesis in rat liver and intestine. The Journal of Nutrition. 1999; 129: 942\u2013948.","DOI":"10.1093\/jn\/129.5.942"},{"key":"ref131","doi-asserted-by":"publisher","unstructured":"den Besten G, Bleeker A, Gerding A, van Eunen K, Havinga R, van Dijk TH, et al. Short-Chain Fatty Acids Protect Against High-Fat Diet-Induced Obesity via a PPAR\u03b3-Dependent Switch From Lipogenesis to Fat Oxidation. Diabetes. 2015; 64: 2398\u20132408.","DOI":"10.2337\/db14-1213"},{"key":"ref132","doi-asserted-by":"publisher","unstructured":"Koh A, De Vadder F, Kovatcheva-Datchary P, B\u00e4ckhed F. From Dietary Fiber to Host Physiology: Short-Chain Fatty Acids as Key Bacterial Metabolites. Cell. 2016; 165: 1332\u20131345.","DOI":"10.1016\/j.cell.2016.05.041"},{"key":"ref133","doi-asserted-by":"publisher","unstructured":"Haghikia A, Zimmermann F, Schumann P, Jasina A, Roessler J, Schmidt D, et al. Propionate attenuates atherosclerosis by immune-dependent regulation of intestinal cholesterol metabolism. European Heart Journal. 2022; 43: 518\u2013533.","DOI":"10.1093\/eurheartj\/ehab644"},{"key":"ref134","doi-asserted-by":"publisher","unstructured":"Zhu W, Gregory JC, Org E, Buffa JA, Gupta N, Wang Z, et al. Gut Microbial Metabolite TMAO Enhances Platelet Hyperreactivity and Thrombosis Risk. Cell. 2016; 165: 111\u2013124.","DOI":"10.1016\/j.cell.2016.02.011"},{"key":"ref135","doi-asserted-by":"publisher","unstructured":"Seldin MM, Meng Y, Qi H, Zhu W, Wang Z, Hazen SL, et al. Trimethylamine N-Oxide Promotes Vascular Inflammation Through Signaling of Mitogen-Activated Protein Kinase and Nuclear Factor-\u03baB. Journal of the American Heart Association. 2016; 5: e002767.","DOI":"10.1161\/JAHA.115.002767"},{"key":"ref136","doi-asserted-by":"publisher","unstructured":"Nagata C, Wada K, Tamura T, Konishi K, Kawachi T, Tsuji M, et al. Choline and Betaine Intakes Are Not Associated with Cardiovascular Disease Mortality Risk in Japanese Men and Women. The Journal of Nutrition. 2015; 145: 1787\u20131792.","DOI":"10.3945\/jn.114.209296"},{"key":"ref137","doi-asserted-by":"publisher","unstructured":"Pietzner M, Stewart ID, Raffler J, Khaw KT, Michelotti GA, Kastenm\u00fcller G, et al. Plasma metabolites to profile pathways in noncommunicable disease multimorbidity. Nature Medicine. 2021; 27: 471\u2013479.","DOI":"10.1038\/s41591-021-01266-0"},{"key":"ref138","doi-asserted-by":"publisher","unstructured":"Molinaro A, Nemet I, Bel Lassen P, Chakaroun R, Nielsen T, Aron-Wisnewsky J, et al. Microbially Produced Imidazole Propionate Is Associated With Heart Failure and Mortality. JACC. Heart Failure. 2023; 11: 810\u2013821.","DOI":"10.1016\/j.jchf.2023.03.008"},{"key":"ref139","doi-asserted-by":"publisher","unstructured":"Tr\u00f8seid M, Ueland T, Hov JR, Svardal A, Gregersen I, Dahl CP, et al. Microbiota-dependent metabolite trimethylamine-N-oxide is associated with disease severity and survival of patients with chronic heart failure. Journal of Internal Medicine. 2015; 277: 717\u2013726.","DOI":"10.1111\/joim.12328"},{"key":"ref140","doi-asserted-by":"publisher","unstructured":"Organ CL, Otsuka H, Bhushan S, Wang Z, Bradley J, Trivedi R, et al. Choline Diet and Its Gut Microbe-Derived Metabolite, Trimethylamine N-Oxide, Exacerbate Pressure Overload-Induced Heart Failure. Circulation. Heart Failure. 2016; 9: e002314.","DOI":"10.1161\/CIRCHEARTFAILURE.115.002314"},{"key":"ref141","doi-asserted-by":"publisher","unstructured":"Tang WHW, Wang Z, Kennedy DJ, Wu Y, Buffa JA, Agatisa-Boyle B, et al. Gut microbiota-dependent trimethylamine N-oxide (TMAO) pathway contributes to both development of renal insufficiency and mortality risk in chronic kidney disease. Circulation Research. 2015; 116: 448\u2013455.","DOI":"10.1161\/CIRCRESAHA.116.305360"},{"key":"ref142","doi-asserted-by":"publisher","unstructured":"Dambrova M, Latkovskis G, Kuka J, Strele I, Konrade I, Grinberga S, et al. Diabetes is Associated with Higher Trimethylamine N-oxide Plasma Levels. Experimental and Clinical Endocrinology & Diabetes. 2016; 124: 251\u2013256.","DOI":"10.1055\/s-0035-1569330"},{"key":"ref143","doi-asserted-by":"publisher","unstructured":"Tang WHW, Wang Z, Li XS, Fan Y, Li DS, Wu Y, et al. Increased Trimethylamine N-Oxide Portends High Mortality Risk Independent of Glycemic Control in Patients with Type 2 Diabetes Mellitus. Clinical Chemistry. 2017; 63: 297\u2013306.","DOI":"10.1373\/clinchem.2016.263640"},{"key":"ref144","doi-asserted-by":"publisher","unstructured":"Miao J, Ling AV, Manthena PV, Gearing ME, Graham MJ, Crooke RM, et al. Flavin-containing monooxygenase 3 as a potential player in diabetes-associated atherosclerosis. Nature Communications. 2015; 6: 6498.","DOI":"10.1038\/ncomms7498"},{"key":"ref145","doi-asserted-by":"publisher","unstructured":"Schugar RC, Shih DM, Warrier M, Helsley RN, Burrows A, Ferguson D, et al. The TMAO-Producing Enzyme Flavin-Containing Monooxygenase 3 Regulates Obesity and the Beiging of White Adipose Tissue. Cell Reports. 2017; 19: 2451\u20132461.","DOI":"10.1016\/j.celrep.2017.05.077"},{"key":"ref146","doi-asserted-by":"publisher","unstructured":"Zhu W, Wang Z, Tang WHW, Hazen SL. Gut Microbe-Generated Trimethylamine N-Oxide From Dietary Choline Is Prothrombotic in Subjects. Circulation. 2017; 135: 1671\u20131673.","DOI":"10.1161\/CIRCULATIONAHA.116.025338"},{"key":"ref147","doi-asserted-by":"publisher","unstructured":"Boini KM, Hussain T, Li PL, Koka S. Trimethylamine-N-Oxide Instigates NLRP3 Inflammasome Activation and Endothelial Dysfunction. Cellular Physiology and Biochemistry. 2017; 44: 152\u2013162.","DOI":"10.1159\/000484623"},{"key":"ref148","doi-asserted-by":"publisher","unstructured":"Chen ML, Zhu XH, Ran L, Lang HD, Yi L, Mi MT. Trimethylamine-N-Oxide Induces Vascular Inflammation by Activating the NLRP3 Inflammasome Through the SIRT3-SOD2-mtROS Signaling Pathway. Journal of the American Heart Association. 2017; 6: e006347.","DOI":"10.1161\/JAHA.117.006347"},{"key":"ref149","doi-asserted-by":"publisher","unstructured":"Wang Z, Roberts AB, Buffa JA, Levison BS, Zhu W, Org E, et al. Non-lethal Inhibition of Gut Microbial Trimethylamine Production for the Treatment of Atherosclerosis. Cell. 2015; 163: 1585\u20131595.","DOI":"10.1016\/j.cell.2015.11.055"},{"key":"ref150","doi-asserted-by":"publisher","unstructured":"Manzini S, Pinna C, Busnelli M, Cinquanta P, Rigamonti E, Ganzetti GS, et al. Beta2-adrenergic activity modulates vascular tone regulation in lecithin:cholesterol acyltransferase knockout mice. Vascular Pharmacology. 2015; 74: 114\u2013121.","DOI":"10.1016\/j.vph.2015.08.006"},{"key":"ref151","doi-asserted-by":"publisher","unstructured":"Collins HL, Drazul-Schrader D, Sulpizio AC, Koster PD, Williamson Y, Adelman SJ, et al. L-Carnitine intake and high trimethylamine N-oxide plasma levels correlate with low aortic lesions in ApoE(-\/-) transgenic mice expressing CETP. Atherosclerosis. 2016; 244: 29\u201337.","DOI":"10.1016\/j.atherosclerosis.2015.10.108"},{"key":"ref152","doi-asserted-by":"publisher","unstructured":"Bidulescu A, Chambless LE, Siega-Riz AM, Zeisel SH, Heiss G. Usual choline and betaine dietary intake and incident coronary heart disease: the Atherosclerosis Risk in Communities (ARIC) study. BMC Cardiovascular Disorders. 2007; 7: 20.","DOI":"10.1186\/1471-2261-7-20"},{"key":"ref153","doi-asserted-by":"publisher","unstructured":"de Aguiar Vallim TQ, Tarling EJ, Edwards PA. Pleiotropic roles of bile acids in metabolism. Cell Metabolism. 2013; 17: 657\u2013669.","DOI":"10.1016\/j.cmet.2013.03.013"},{"key":"ref154","doi-asserted-by":"publisher","unstructured":"Sato Y, Atarashi K, Plichta DR, Arai Y, Sasajima S, Kearney SM, et al. Novel bile acid biosynthetic pathways are enriched in the microbiome of centenarians. Nature. 2021; 599: 458\u2013464.","DOI":"10.1038\/s41586-021-03832-5"},{"key":"ref155","doi-asserted-by":"publisher","unstructured":"Sui Y, Xu J, Rios-Pilier J, Zhou C. Deficiency of PXR decreases atherosclerosis in apoE-deficient mice. Journal of Lipid Research. 2011; 52: 1652\u20131659.","DOI":"10.1194\/jlr.M017376"},{"key":"ref156","doi-asserted-by":"publisher","unstructured":"Hautala AJ, Tulppo MP, Kiviniemi AM, Rankinen T, Bouchard C, M\u00e4kikallio TH, et al. Acetylcholine receptor M2 gene variants, heart rate recovery, and risk of cardiac death after an acute myocardial infarction. Annals of Medicine. 2009; 41: 197\u2013207.","DOI":"10.1080\/07853890802477866"},{"key":"ref157","doi-asserted-by":"publisher","unstructured":"Studer E, Zhou X, Zhao R, Wang Y, Takabe K, Nagahashi M, et al. Conjugated bile acids activate the sphingosine-1-phosphate receptor 2 in primary rodent hepatocytes. Hepatology (Baltimore, Md.). 2012; 55: 267\u2013276.","DOI":"10.1002\/hep.24681"},{"key":"ref158","doi-asserted-by":"publisher","unstructured":"Skoura A, Michaud J, Im DS, Thangada S, Xiong Y, Smith JD, et al. Sphingosine-1-phosphate receptor-2 function in myeloid cells regulates vascular inflammation and atherosclerosis. Arteriosclerosis, Thrombosis, and Vascular Biology. 2011; 31: 81\u201385.","DOI":"10.1161\/ATVBAHA.110.213496"},{"key":"ref159","doi-asserted-by":"publisher","unstructured":"Lynch CJ, Adams SH. Branched-chain amino acids in metabolic signalling and insulin resistance. Nature Reviews. Endocrinology. 2014; 10: 723\u2013736.","DOI":"10.1038\/nrendo.2014.171"},{"key":"ref160","doi-asserted-by":"publisher","unstructured":"Paraskevaidis I, Tsougos E, Kourek C. The Microbiome Connection: A Common Pathway Linking Cancer and Heart Failure. Biomedicines. 2025; 13: 1297.","DOI":"10.3390\/biomedicines13061297"},{"key":"ref161","doi-asserted-by":"publisher","unstructured":"Molinaro A, Bel Lassen P, Henricsson M, Wu H, Adriouch S, Belda E, et al. Imidazole propionate is increased in diabetes and associated with dietary patterns and altered microbial ecology. Nature Communications. 2020; 11: 5881.","DOI":"10.1038\/s41467-020-19589-w"},{"key":"ref162","doi-asserted-by":"publisher","unstructured":"Nemet I, Saha PP, Gupta N, Zhu W, Romano KA, Skye SM, et al. A Cardiovascular Disease-Linked Gut Microbial Metabolite Acts via Adrenergic Receptors. Cell. 2020; 180: 862\u2013877.e22.","DOI":"10.1016\/j.cell.2020.02.016"},{"key":"ref163","doi-asserted-by":"publisher","unstructured":"Menni C, Zhu J, Le Roy CI, Mompeo O, Young K, Rebholz CM, et al. Serum metabolites reflecting gut microbiome alpha diversity predict type 2 diabetes. Gut Microbes. 2020; 11: 1632\u20131642.","DOI":"10.1080\/19490976.2020.1778261"},{"key":"ref164","doi-asserted-by":"publisher","unstructured":"Esc\u00f3s A, Risco A, Alsina-Beauchamp D, Cuenda A. p38\u03b3 and p38\u03b4 Mitogen Activated Protein Kinases (MAPKs), New Stars in the MAPK Galaxy. Frontiers in Cell and Developmental Biology. 2016; 4: 31.","DOI":"10.3389\/fcell.2016.00031"},{"key":"ref165","doi-asserted-by":"publisher","unstructured":"Koh A, Molinaro A, St\u00e5hlman M, Khan MT, Schmidt C, Manner\u00e5s-Holm L, et al. Microbially Produced Imidazole Propionate Impairs Insulin Signaling through mTORC1. Cell. 2018; 175: 947\u2013961.e17.","DOI":"10.1016\/j.cell.2018.09.055"},{"key":"ref166","doi-asserted-by":"publisher","unstructured":"Koh A, Manner\u00e5s-Holm L, Yunn NO, Nilsson PM, Ryu SH, Molinaro A, et al. Microbial Imidazole Propionate Affects Responses to Metformin through p38\u03b3-Dependent Inhibitory AMPK Phosphorylation. Cell Metabolism. 2020; 32: 643\u2013653.e4.","DOI":"10.1016\/j.cmet.2020.07.012"},{"key":"ref167","doi-asserted-by":"publisher","unstructured":"Nageswaran V, Carreras A, Reinshagen L, Beck KR, Steinfeldt J, Henricsson M, et al. Gut Microbial Metabolite Imidazole Propionate Impairs Endothelial Cell Function and Promotes the Development of Atherosclerosis. Arteriosclerosis, Thrombosis, and Vascular Biology. 2025; 45: 823\u2013839.","DOI":"10.1161\/ATVBAHA.124.322346"},{"key":"ref168","doi-asserted-by":"publisher","unstructured":"Stephenson J, Nutma E, van der Valk P, Amor S. Inflammation in CNS neurodegenerative diseases. Immunology. 2018; 154: 204\u2013219.","DOI":"10.1111\/imm.12922"},{"key":"ref169","doi-asserted-by":"publisher","unstructured":"Brambilla R. The contribution of astrocytes to the neuroinflammatory response in multiple sclerosis and experimental autoimmune encephalomyelitis. Acta Neuropathologica. 2019; 137: 757\u2013783.","DOI":"10.1007\/s00401-019-01980-7"},{"key":"ref170","doi-asserted-by":"publisher","unstructured":"Klingelhoefer L, Reichmann H. Pathogenesis of Parkinson disease\u2013the gut-brain axis and environmental factors. Nature Reviews. Neurology. 2015; 11: 625\u2013636.","DOI":"10.1038\/nrneurol.2015.197"},{"key":"ref171","doi-asserted-by":"publisher","unstructured":"Sharon G, Sampson TR, Geschwind DH, Mazmanian SK. The Central Nervous System and the Gut Microbiome. Cell. 2016; 167: 915\u2013932.","DOI":"10.1016\/j.cell.2016.10.027"},{"key":"ref172","doi-asserted-by":"publisher","unstructured":"Claesson MJ, Jeffery IB, Conde S, Power SE, O\u2019Connor EM, Cusack S, et al. Gut microbiota composition correlates with diet and health in the elderly. Nature. 2012; 488: 178\u2013184.","DOI":"10.1038\/nature11319"},{"key":"ref173","doi-asserted-by":"publisher","unstructured":"Liu X, Cao S, Zhang X. Modulation of Gut Microbiota-Brain Axis by Probiotics, Prebiotics, and Diet. Journal of Agricultural and Food Chemistry. 2015; 63: 7885\u20137895.","DOI":"10.1021\/acs.jafc.5b02404"},{"key":"ref174","doi-asserted-by":"publisher","unstructured":"Stilling RM, van de Wouw M, Clarke G, Stanton C, Dinan TG, Cryan JF. The neuropharmacology of butyrate: The bread and butter of the microbiota-gut-brain axis? Neurochemistry International. 2016; 99: 110\u2013132.","DOI":"10.1016\/j.neuint.2016.06.011"},{"key":"ref175","doi-asserted-by":"publisher","unstructured":"Clarke G, Stilling RM, Kennedy PJ, Stanton C, Cryan JF, Dinan TG. Minireview: Gut microbiota: the neglected endocrine organ. Molecular Endocrinology (Baltimore, Md.). 2014; 28: 1221\u20131238.","DOI":"10.1210\/me.2014-1108"},{"key":"ref176","doi-asserted-by":"publisher","unstructured":"Dalile B, Van Oudenhove L, Vervliet B, Verbeke K. The role of short-chain fatty acids in microbiota-gut-brain communication. Nature Reviews. Gastroenterology & Hepatology. 2019; 16: 461\u2013478.","DOI":"10.1038\/s41575-019-0157-3"},{"key":"ref177","doi-asserted-by":"publisher","unstructured":"Brunt VE, LaRocca TJ, Bazzoni AE, Sapinsley ZJ, Miyamoto-Ditmon J, Gioscia-Ryan RA, et al. The gut microbiome-derived metabolite trimethylamine N-oxide modulates neuroinflammation and cognitive function with aging. GeroScience. 2021; 43: 377\u2013394.","DOI":"10.1007\/s11357-020-00257-2"},{"key":"ref178","doi-asserted-by":"publisher","unstructured":"Tha KK, Okuma Y, Miyazaki H, Murayama T, Uehara T, Hatakeyama R, et al. Changes in expressions of proinflammatory cytokines IL-1beta, TNF-alpha and IL-6 in the brain of senescence accelerated mouse (SAM) P8. Brain Research. 2000; 885: 25\u201331.","DOI":"10.1016\/s0006-8993(00)02883-3"},{"key":"ref179","doi-asserted-by":"publisher","unstructured":"Godbout JP, Johnson RW. Interleukin-6 in the aging brain. Journal of Neuroimmunology. 2004; 147: 141\u2013144.","DOI":"10.1016\/j.jneuroim.2003.10.031"},{"key":"ref180","doi-asserted-by":"publisher","unstructured":"Csipo T, Lipecz A, Ashpole NM, Balasubramanian P, Tarantini S. Astrocyte senescence contributes to cognitive decline. GeroScience. 2020; 42: 51\u201355.","DOI":"10.1007\/s11357-019-00140-9"},{"key":"ref181","doi-asserted-by":"publisher","unstructured":"Cuartero MI, Garc\u00eda-Culebras A, Nieto-Vaquero C, Fraga E, Torres-L\u00f3pez C, Pradillo J, et al. The role of gut microbiota in cerebrovascular disease and related dementia. British Journal of Pharmacology. 2024; 181: 816\u2013839.","DOI":"10.1111\/bph.16167"},{"key":"ref182","doi-asserted-by":"publisher","unstructured":"Jacob SM, Lee S, Kim SH, Sharkey KA, Pfeffer G, Nguyen MD. Brain-body mechanisms contribute to sexual dimorphism in amyotrophic lateral sclerosis. Nature Reviews. Neurology. 2024; 20: 475\u2013494.","DOI":"10.1038\/s41582-024-00991-7"},{"key":"ref183","doi-asserted-by":"publisher","unstructured":"McGuire V, Longstreth WT, Jr, Koepsell TD, van Belle G. Incidence of amyotrophic lateral sclerosis in three counties in western Washington state. Neurology. 1996; 47: 571\u2013573.","DOI":"10.1212\/wnl.47.2.571"},{"key":"ref184","doi-asserted-by":"publisher","unstructured":"Masrori P, Van Damme P. Amyotrophic lateral sclerosis: a clinical review. European Journal of Neurology. 2020; 27: 1918\u20131929.","DOI":"10.1111\/ene.14393"},{"key":"ref185","doi-asserted-by":"publisher","unstructured":"Zhang H, Chen L, Tian J, Fan D. Disease duration of progression is helpful in identifying isolated bulbar palsy of amyotrophic lateral sclerosis. BMC Neurology. 2021; 21: 405.","DOI":"10.1186\/s12883-021-02438-8"},{"key":"ref186","doi-asserted-by":"publisher","unstructured":"Marchesi M, Parolini C, Valetti C, Mangione P, Obici L, Giorgetti S, et al. The intracellular quality control system down-regulates the secretion of amyloidogenic apolipoprotein A-I variants: a possible impact on the natural history of the disease. Biochimica et Biophysica Acta. 2011; 1812: 87\u201393.","DOI":"10.1016\/j.bbadis.2010.07.002"},{"key":"ref187","doi-asserted-by":"publisher","unstructured":"Farina S, Esposito F, Battistoni M, Biamonti G, Francia S. Post-Translational Modifications Modulate Proteinopathies of TDP-43, FUS and hnRNP-A\/B in Amyotrophic Lateral Sclerosis. Frontiers in Molecular Biosciences. 2021; 8: 693325.","DOI":"10.3389\/fmolb.2021.693325"},{"key":"ref188","doi-asserted-by":"publisher","unstructured":"Modafferi S, Farina S, Esposito F, Brandi O, Di Salvio M, Della Valle I, et al. DNA damage response defects induced by the formation of TDP-43 and mutant FUS cytoplasmic inclusions and their pharmacological rescue. Cell Death and Differentiation. 2025.  (online ahead of print)","DOI":"10.1038\/s41418-025-01530-7"},{"key":"ref189","doi-asserted-by":"publisher","unstructured":"Feldman EL, Goutman SA, Petri S, Mazzini L, Savelieff MG, Shaw PJ, et al. Amyotrophic lateral sclerosis. Lancet (London, England). 2022; 400: 1363\u20131380.","DOI":"10.1016\/S0140-6736(22)01272-7"},{"key":"ref190","doi-asserted-by":"publisher","unstructured":"Mejzini R, Flynn LL, Pitout IL, Fletcher S, Wilton SD, Akkari PA. ALS Genetics, Mechanisms, and Therapeutics: Where Are We Now? Frontiers in Neuroscience. 2019; 13: 1310.","DOI":"10.3389\/fnins.2019.01310"},{"key":"ref191","doi-asserted-by":"publisher","unstructured":"Murdock BJ, Zhou T, Kashlan SR, Little RJ, Goutman SA, Feldman EL. Correlation of Peripheral Immunity With Rapid Amyotrophic Lateral Sclerosis Progression. JAMA Neurology. 2017; 74: 1446\u20131454.","DOI":"10.1001\/jamaneurol.2017.2255"},{"key":"ref192","doi-asserted-by":"publisher","unstructured":"Bouteloup C, Desport JC, Clavelou P, Guy N, Derumeaux-Burel H, Ferrier A, et al. Hypermetabolism in ALS patients: an early and persistent phenomenon. Journal of Neurology. 2009; 256: 1236\u20131242.","DOI":"10.1007\/s00415-009-5100-z"},{"key":"ref193","doi-asserted-by":"publisher","unstructured":"Hobson EV, McDermott CJ. Supportive and symptomatic management of amyotrophic lateral sclerosis. Nature Reviews. Neurology. 2016; 12: 526\u2013538.","DOI":"10.1038\/nrneurol.2016.111"},{"key":"ref194","doi-asserted-by":"publisher","unstructured":"Cuffaro F, Lamminp\u00e4\u00e4 I, Niccolai E, Amedei A. Nutritional and Microbiota-Based Approaches in Amyotrophic Lateral Sclerosis: From Prevention to Treatment. Nutrients. 2024; 17: 102.","DOI":"10.3390\/nu17010102"},{"key":"ref195","doi-asserted-by":"publisher","unstructured":"Zhang L, Zhuang Z, Zhang G, Huang T, Fan D. Assessment of bidirectional relationships between 98 genera of the human gut microbiota and amyotrophic lateral sclerosis: a 2-sample Mendelian randomization study. BMC Neurology. 2022; 22: 8.","DOI":"10.1186\/s12883-021-02522-z"},{"key":"ref196","doi-asserted-by":"publisher","unstructured":"Rowin J, Xia Y, Jung B, Sun J. Gut inflammation and dysbiosis in human motor neuron disease. Physiological Reports. 2017; 5: e13443.","DOI":"10.14814\/phy2.13443"},{"key":"ref197","doi-asserted-by":"publisher","unstructured":"Natale G, Pasquali L, Paparelli A, Fornai F. Parallel manifestations of neuropathologies in the enteric and central nervous systems. Neurogastroenterology and Motility. 2011; 23: 1056\u20131065.","DOI":"10.1111\/j.1365-2982.2011.01794.x"},{"key":"ref198","doi-asserted-by":"publisher","unstructured":"Herdewyn S, Cirillo C, Van Den Bosch L, Robberecht W, Vanden Berghe P, Van Damme P. Prevention of intestinal obstruction reveals progressive neurodegeneration in mutant TDP-43 (A315T) mice. Molecular Neurodegeneration. 2014; 9: 24.","DOI":"10.1186\/1750-1326-9-24"},{"key":"ref199","doi-asserted-by":"publisher","unstructured":"Blacher E, Bashiardes S, Shapiro H, Rothschild D, Mor U, Dori-Bachash M, et al. Potential roles of gut microbiome and metabolites in modulating ALS in mice. Nature. 2019; 572: 474\u2013480.","DOI":"10.1038\/s41586-019-1443-5"},{"key":"ref200","doi-asserted-by":"publisher","unstructured":"Niccolai E, Di Gloria L, Trolese MC, Fabbrizio P, Baldi S, Nannini G, et al. Host genetics and gut microbiota influence lipid metabolism and inflammation: potential implications for ALS pathophysiology in SOD1G93A mice. Acta Neuropathologica Communications. 2024; 12: 174.","DOI":"10.1186\/s40478-024-01877-x"},{"key":"ref201","doi-asserted-by":"publisher","unstructured":"Burberry A, Wells MF, Limone F, Couto A, Smith KS, Keaney J, et al. C9orf72 suppresses systemic and neural inflammation induced by gut bacteria. Nature. 2020; 582: 89\u201394.","DOI":"10.1038\/s41586-020-2288-7"},{"key":"ref202","doi-asserted-by":"publisher","unstructured":"Kira Y, Nishikawa M, Ochi A, Sato E, Inoue M. L-carnitine suppresses the onset of neuromuscular degeneration and increases the life span of mice with familial amyotrophic lateral sclerosis. Brain Research. 2006; 1070: 206\u2013214.","DOI":"10.1016\/j.brainres.2005.11.052"},{"key":"ref203","doi-asserted-by":"publisher","unstructured":"Getter T, Zaks I, Barhum Y, Ben-Zur T, B\u00f6selt S, Gregoire S, et al. A chemical chaperone-based drug candidate is effective in a mouse model of amyotrophic lateral sclerosis (ALS). ChemMedChem. 2015; 10: 850\u2013861.","DOI":"10.1002\/cmdc.201500045"},{"key":"ref204","doi-asserted-by":"publisher","unstructured":"Beghi E, Pupillo E, Bonito V, Buzzi P, Caponnetto C, Chi\u00f2 A, et al. Randomized double-blind placebo-controlled trial of acetyl-L-carnitine for ALS. Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration. 2013; 14: 397\u2013405.","DOI":"10.3109\/21678421.2013.764568"},{"key":"ref205","doi-asserted-by":"publisher","unstructured":"Gotkine M, Kviatcovsky D, Elinav E. Amyotrophic lateral sclerosis and intestinal microbiota-toward establishing cause and effect. Gut Microbes. 2020; 11: 1833\u20131841.","DOI":"10.1080\/19490976.2020.1767464"},{"key":"ref206","doi-asserted-by":"publisher","unstructured":"Nicholson K, Bjornevik K, Abu-Ali G, Chan J, Cortese M, Dedi B, et al. The human gut microbiota in people with amyotrophic lateral sclerosis. Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration. 2021; 22: 186\u2013194.","DOI":"10.1080\/21678421.2020.1828475"},{"key":"ref207","doi-asserted-by":"publisher","unstructured":"Niccolai E, Di Pilato V, Nannini G, Baldi S, Russo E, Zucchi E, et al. The Gut Microbiota-Immunity Axis in ALS: A Role in Deciphering Disease Heterogeneity? Biomedicines. 2021; 9: 753.","DOI":"10.3390\/biomedicines9070753"},{"key":"ref208","doi-asserted-by":"publisher","unstructured":"Ngo ST, Restuadi R, McCrae AF, Van Eijk RP, Garton F, Henderson RD, et al. Progression and survival of patients with motor neuron disease relative to their fecal microbiota. Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration. 2020; 21: 549\u2013562.","DOI":"10.1080\/21678421.2020.1772825"},{"key":"ref209","doi-asserted-by":"publisher","unstructured":"Sun J, Zhan Y, Mariosa D, Larsson H, Almqvist C, Ingre C, et al. Antibiotics use and risk of amyotrophic lateral sclerosis in Sweden. European Journal of Neurology. 2019; 26: 1355\u20131361.","DOI":"10.1111\/ene.13986"},{"key":"ref210","doi-asserted-by":"publisher","unstructured":"Chen L, Chen Y, Zhao M, Zheng L, Fan D. Changes in the concentrations of trimethylamine N-oxide (TMAO) and its precursors in patients with amyotrophic lateral sclerosis. Scientific Reports. 2020; 10: 15198.","DOI":"10.1038\/s41598-020-72184-3"},{"key":"ref211","doi-asserted-by":"publisher","unstructured":"GBD 2016 Neurology Collaborators. Global, regional, and national burden of neurological disorders, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016. The Lancet. Neurology. 2019; 18: 459\u2013480.","DOI":"10.1016\/S1474-4422(18)30499-X"},{"key":"ref212","doi-asserted-by":"publisher","unstructured":"Arrona Cardoza P, Spillane MB, Morales Marroquin E. Alzheimer\u2019s disease and gut microbiota: does trimethylamine N-oxide (TMAO) play a role? Nutrition Reviews. 2022; 80: 271\u2013281.","DOI":"10.1093\/nutrit\/nuab022"},{"key":"ref213","doi-asserted-by":"publisher","unstructured":"Wimo A, Guerchet M, Ali GC, Wu YT, Prina AM, Winblad B, et al. The worldwide costs of dementia 2015 and comparisons with 2010. Alzheimer\u2019s & Dementia: the Journal of the Alzheimer\u2019s Association. 2017; 13: 1\u20137.","DOI":"10.1016\/j.jalz.2016.07.150"},{"key":"ref214","doi-asserted-by":"publisher","unstructured":"Schliebs R, Arendt T. The cholinergic system in aging and neuronal degeneration. Behavioural Brain Research. 2011; 221: 555\u2013563.","DOI":"10.1016\/j.bbr.2010.11.058"},{"key":"ref215","doi-asserted-by":"publisher","unstructured":"Jouanne M, Rault S, Voisin-Chiret AS. Tau protein aggregation in Alzheimer\u2019s disease: An attractive target for the development of novel therapeutic agents. European Journal of Medicinal Chemistry. 2017; 139: 153\u2013167.","DOI":"10.1016\/j.ejmech.2017.07.070"},{"key":"ref216","doi-asserted-by":"publisher","unstructured":"Kumar A, Singh A, Ekavali. A review on Alzheimer\u2019s disease pathophysiology and its management: an update. Pharmacological Reports: PR. 2015; 67: 195\u2013203.","DOI":"10.1016\/j.pharep.2014.09.004"},{"key":"ref217","doi-asserted-by":"publisher","unstructured":"Masters CL, Bateman R, Blennow K, Rowe CC, Sperling RA, Cummings JL. Alzheimer\u2019s disease. Nature Reviews. Disease Primers. 2015; 1: 15056.","DOI":"10.1038\/nrdp.2015.56"},{"key":"ref218","doi-asserted-by":"publisher","unstructured":"ElAli A, Rivest S. Microglia in Alzheimer\u2019s disease: A multifaceted relationship. Brain, Behavior, and Immunity. 2016; 55: 138\u2013150.","DOI":"10.1016\/j.bbi.2015.07.021"},{"key":"ref219","doi-asserted-by":"publisher","unstructured":"Osborn LM, Kamphuis W, Wadman WJ, Hol EM. Astrogliosis: An integral player in the pathogenesis of Alzheimer\u2019s disease. Progress in Neurobiology. 2016; 144: 121\u2013141.","DOI":"10.1016\/j.pneurobio.2016.01.001"},{"key":"ref220","doi-asserted-by":"publisher","unstructured":"Heneka MT, van der Flier WM, Jessen F, Hoozemanns J, Thal DR, Boche D, et al. Neuroinflammation in Alzheimer disease. Nature Reviews. Immunology. 2025; 25: 321\u2013352.","DOI":"10.1038\/s41577-024-01104-7"},{"key":"ref221","doi-asserted-by":"publisher","unstructured":"Fraser T, Tayler H, Love S. Fatty acid composition of frontal, temporal and parietal neocortex in the normal human brain and in Alzheimer\u2019s disease. Neurochemical Research. 2010; 35: 503\u2013513.","DOI":"10.1007\/s11064-009-0087-5"},{"key":"ref222","doi-asserted-by":"publisher","unstructured":"Yassine HN, Feng Q, Azizkhanian I, Rawat V, Castor K, Fonteh AN, et al. Association of Serum Docosahexaenoic Acid With Cerebral Amyloidosis. JAMA Neurology. 2016; 73: 1208\u20131216.","DOI":"10.1001\/jamaneurol.2016.1924"},{"key":"ref223","doi-asserted-by":"publisher","unstructured":"Friedland RP. Mechanisms of molecular mimicry involving the microbiota in neurodegeneration. Journal of Alzheimer\u2019s Disease: JAD. 2015; 45: 349\u2013362.","DOI":"10.3233\/JAD-142841"},{"key":"ref224","doi-asserted-by":"publisher","unstructured":"Peng W, Yi P, Yang J, Xu P, Wang Y, Zhang Z, et al. Association of gut microbiota composition and function with a senescence-accelerated mouse model of Alzheimer\u2019s Disease using 16S rRNA gene and metagenomic sequencing analysis. Aging. 2018; 10: 4054\u20134065.","DOI":"10.18632\/aging.101693"},{"key":"ref225","doi-asserted-by":"publisher","unstructured":"Valeri F, Dos Santos Guilherme M, He F, Stoye NM, Schwiertz A, Endres K. Impact of the Age of Cecal Material Transfer Donors on Alzheimer\u2019s Disease Pathology in 5xFAD Mice. Microorganisms. 2021; 9: 2548.","DOI":"10.3390\/microorganisms9122548"},{"key":"ref226","doi-asserted-by":"publisher","unstructured":"Cheng X, Tan Y, Li H, Huang J, Zhao D, Zhang Z, et al. Fecal 16S rRNA sequencing and multi-compartment metabolomics revealed gut microbiota and metabolites interactions in APP\/PS1 mice. Computers in Biology and Medicine. 2022; 151: 106312.","DOI":"10.1016\/j.compbiomed.2022.106312"},{"key":"ref227","doi-asserted-by":"publisher","unstructured":"van Olst L, Roks SJM, Kamermans A, Verhaar BJH, van der Geest AM, Muller M, et al. Contribution of Gut Microbiota to Immunological Changes in Alzheimer\u2019s Disease. Frontiers in Immunology. 2021; 12: 683068.","DOI":"10.3389\/fimmu.2021.683068"},{"key":"ref228","doi-asserted-by":"publisher","unstructured":"Zhuang ZQ, Shen LL, Li WW, Fu X, Zeng F, Gui L, et al. Gut Microbiota is Altered in Patients with Alzheimer\u2019s Disease. Journal of Alzheimer\u2019s Disease: JAD. 2018; 63: 1337\u20131346.","DOI":"10.3233\/JAD-180176"},{"key":"ref229","doi-asserted-by":"publisher","unstructured":"Haran JP, Bhattarai SK, Foley SE, Dutta P, Ward DV, Bucci V, et al. Alzheimer\u2019s Disease Microbiome Is Associated with Dysregulation of the Anti-Inflammatory P-Glycoprotein Pathway. mBio. 2019; 10: e00632\u201319.","DOI":"10.1128\/mBio.00632-19"},{"key":"ref230","doi-asserted-by":"publisher","unstructured":"Liu P, Wu L, Peng G, Han Y, Tang R, Ge J, et al. Altered microbiomes distinguish Alzheimer\u2019s disease from amnestic mild cognitive impairment and health in a Chinese cohort. Brain, Behavior, and Immunity. 2019; 80: 633\u2013643.","DOI":"10.1016\/j.bbi.2019.05.008"},{"key":"ref231","doi-asserted-by":"publisher","unstructured":"Verhaar BJH, Hendriksen HMA, de Leeuw FA, Doorduijn AS, van Leeuwenstijn M, Teunissen CE, et al. Gut Microbiota Composition Is Related to AD Pathology. Frontiers in Immunology. 2022; 12: 794519.","DOI":"10.3389\/fimmu.2021.794519"},{"key":"ref232","doi-asserted-by":"publisher","unstructured":"Fernando WMADB, Martins IJ, Morici M, Bharadwaj P, Rainey-Smith SR, Lim WLF, et al. Sodium Butyrate Reduces Brain Amyloid-\u03b2 Levels and Improves Cognitive Memory Performance in an Alzheimer\u2019s Disease Transgenic Mouse Model at an Early Disease Stage. Journal of Alzheimer\u2019s Disease: JAD. 2020; 74: 91\u201399.","DOI":"10.3233\/JAD-190120"},{"key":"ref233","doi-asserted-by":"publisher","unstructured":"Sun J, Xu J, Ling Y, Wang F, Gong T, Yang C, et al. Fecal microbiota transplantation alleviated Alzheimer\u2019s disease-like pathogenesis in APP\/PS1 transgenic mice. Translational Psychiatry. 2019; 9: 189.","DOI":"10.1038\/s41398-019-0525-3"},{"key":"ref234","doi-asserted-by":"publisher","unstructured":"Kim MS, Kim Y, Choi H, Kim W, Park S, Lee D, et al. Transfer of a healthy microbiota reduces amyloid and tau pathology in an Alzheimer\u2019s disease animal model. Gut. 2020; 69: 283\u2013294.","DOI":"10.1136\/gutjnl-2018-317431"},{"key":"ref235","doi-asserted-by":"publisher","unstructured":"Li D, Ke Y, Zhan R, Liu C, Zhao M, Zeng A, et al. Trimethylamine-N-oxide promotes brain aging and cognitive impairment in mice. Aging Cell. 2018; 17: e12768.","DOI":"10.1111\/acel.12768"},{"key":"ref236","doi-asserted-by":"publisher","unstructured":"Gao Q, Wang Y, Wang X, Fu S, Zhang X, Wang RT, et al. Decreased levels of circulating trimethylamine N-oxide alleviate cognitive and pathological deterioration in transgenic mice: a potential therapeutic approach for Alzheimer\u2019s disease. Aging. 2019; 11: 8642\u20138663.","DOI":"10.18632\/aging.102352"},{"key":"ref237","doi-asserted-by":"publisher","unstructured":"Xu R, Wang Q. Towards understanding brain-gut-microbiome connections in Alzheimer\u2019s disease. BMC Systems Biology. 2016; 10: 63.","DOI":"10.1186\/s12918-016-0307-y"},{"key":"ref238","doi-asserted-by":"publisher","unstructured":"Del Rio D, Zimetti F, Caffarra P, Tassotti M, Bernini F, Brighenti F, et al. The Gut Microbial Metabolite Trimethylamine-N-Oxide Is Present in Human Cerebrospinal Fluid. Nutrients. 2017; 9: 1053.","DOI":"10.3390\/nu9101053"},{"key":"ref239","doi-asserted-by":"publisher","unstructured":"Vogt NM, Romano KA, Darst BF, Engelman CD, Johnson SC, Carlsson CM, et al. The gut microbiota-derived metabolite trimethylamine N-oxide is elevated in Alzheimer\u2019s disease. Alzheimer\u2019s Research & Therapy. 2018; 10: 124.","DOI":"10.1186\/s13195-018-0451-2"},{"key":"ref240","doi-asserted-by":"publisher","unstructured":"Tseng HC, Graves DJ. Natural methylamine osmolytes, trimethylamine N-oxide and betaine, increase tau-induced polymerization of microtubules. Biochemical and Biophysical Research Communications. 1998; 250: 726\u2013730.","DOI":"10.1006\/bbrc.1998.9382"},{"key":"ref241","doi-asserted-by":"publisher","unstructured":"Yang DS, Yip CM, Huang TH, Chakrabartty A, Fraser PE. Manipulating the amyloid-beta aggregation pathway with chemical chaperones. The Journal of Biological Chemistry. 1999; 274: 32970\u201332974.","DOI":"10.1074\/jbc.274.46.32970"},{"key":"ref242","doi-asserted-by":"publisher","unstructured":"Scaramozzino F, Peterson DW, Farmer P, Gerig JT, Graves DJ, Lew J. TMAO promotes fibrillization and microtubule assembly activity in the C-terminal repeat region of tau. Biochemistry. 2006; 45: 3684\u20133691.","DOI":"10.1021\/bi052167g"},{"key":"ref243","doi-asserted-by":"publisher","unstructured":"Hao K, Di Narzo AF, Ho L, Luo W, Li S, Chen R, et al. Shared genetic etiology underlying Alzheimer\u2019s disease and type 2 diabetes. Molecular Aspects of Medicine. 2015; 43\u201344: 66\u201376.","DOI":"10.1016\/j.mam.2015.06.006"},{"key":"ref244","doi-asserted-by":"publisher","unstructured":"Arai H, Lee VM, Messinger ML, Greenberg BD, Lowery DE, Trojanowski JQ. Expression patterns of beta-amyloid precursor protein (beta-APP) in neural and nonneural human tissues from Alzheimer\u2019s disease and control subjects. Annals of Neurology. 1991; 30: 686\u2013693.","DOI":"10.1002\/ana.410300509"},{"key":"ref245","doi-asserted-by":"publisher","unstructured":"Puig KL, Swigost AJ, Zhou X, Sens MA, Combs CK. Amyloid precursor protein expression modulates intestine immune phenotype. Journal of Neuroimmune Pharmacology. 2012; 7: 215\u2013230.","DOI":"10.1007\/s11481-011-9327-y"},{"key":"ref246","doi-asserted-by":"publisher","unstructured":"Joachim CL, Mori H, Selkoe DJ. Amyloid beta-protein deposition in tissues other than brain in Alzheimer\u2019s disease. Nature. 1989; 341: 226\u2013230.","DOI":"10.1038\/341226a0"},{"key":"ref247","doi-asserted-by":"publisher","unstructured":"Chalazonitis A, Rao M. Enteric nervous system manifestations of neurodegenerative disease. Brain Research. 2018; 1693: 207\u2013213.","DOI":"10.1016\/j.brainres.2018.01.011"},{"key":"ref248","doi-asserted-by":"publisher","unstructured":"Semar S, Klotz M, Letiembre M, Van Ginneken C, Braun A, Jost V, et al. Changes of the enteric nervous system in amyloid-\u03b2 protein precursor transgenic mice correlate with disease progression. Journal of Alzheimer\u2019s Disease: JAD. 2013; 36: 7\u201320.","DOI":"10.3233\/JAD-120511"},{"key":"ref249","doi-asserted-by":"publisher","unstructured":"Brandscheid C, Schuck F, Reinhardt S, Sch\u00e4fer KH, Pietrzik CU, Grimm M, et al. Altered Gut Microbiome Composition and Tryptic Activity of the 5xFAD Alzheimer\u2019s Mouse Model. Journal of Alzheimer\u2019s Disease: JAD. 2017; 56: 775\u2013788.","DOI":"10.3233\/JAD-160926"},{"key":"ref250","doi-asserted-by":"publisher","unstructured":"Thaler JP, Yi CX, Schur EA, Guyenet SJ, Hwang BH, Dietrich MO, et al. Obesity is associated with hypothalamic injury in rodents and humans. The Journal of Clinical Investigation. 2012; 122: 153\u2013162.","DOI":"10.1172\/JCI59660"},{"key":"ref251","doi-asserted-by":"publisher","unstructured":"Grasset E, Puel A, Charpentier J, Collet X, Christensen JE, Terc\u00e9 F, et al. A Specific Gut Microbiota Dysbiosis of Type 2 Diabetic Mice Induces GLP-1 Resistance through an Enteric NO-Dependent and Gut-Brain Axis Mechanism. Cell Metabolism. 2017; 25: 1075\u20131090.e5.","DOI":"10.1016\/j.cmet.2017.04.013"},{"key":"ref252","doi-asserted-by":"publisher","unstructured":"Terzolo M, Pia A, Al\u00ec A, Osella G, Reimondo G, Bovio S, et al. Adrenal incidentaloma: a new cause of the metabolic syndrome? The Journal of Clinical Endocrinology and Metabolism. 2002; 87: 998\u20131003.","DOI":"10.1210\/jcem.87.3.8277"},{"key":"ref253","doi-asserted-by":"publisher","unstructured":"Lucassen EA, Cizza G. The Hypothalamic-Pituitary-Adrenal Axis, Obesity, and Chronic Stress Exposure: Sleep and the HPA Axis in Obesity. Current Obesity Reports. 2012; 1: 208\u2013215.","DOI":"10.1007\/s13679-012-0028-5"},{"key":"ref254","doi-asserted-by":"publisher","unstructured":"Pasquali R, Cantobelli S, Casimirri F, Capelli M, Bortoluzzi L, Flamia R, et al. The hypothalamic-pituitary-adrenal axis in obese women with different patterns of body fat distribution. The Journal of Clinical Endocrinology and Metabolism. 1993; 77: 341\u2013346.","DOI":"10.1210\/jcem.77.2.8393881"},{"key":"ref255","doi-asserted-by":"publisher","unstructured":"Vicennati V, Ceroni L, Gagliardi L, Pagotto U, Gambineri A, Genghini S, et al. Response of the hypothalamic-pituitary-adrenal axis to small dose arginine-vasopressin and daily urinary free cortisol before and after alprazolam pre-treatment differs in obesity. Journal of Endocrinological Investigation. 2004; 27: 541\u2013547.","DOI":"10.1007\/BF03347476"},{"key":"ref256","doi-asserted-by":"publisher","unstructured":"Bertagna X, Coste J, Raux-Demay MC, Letrait M, Strauch G. The combined corticotropin-releasing hormone\/lysine vasopressin test discloses a corticotroph phenotype. The Journal of Clinical Endocrinology and Metabolism. 1994; 79: 390\u2013394.","DOI":"10.1210\/jcem.79.2.8045953"},{"key":"ref257","doi-asserted-by":"publisher","unstructured":"Salvadori A, Fanari P, Giacomotti E, Palmulli P, Bolla G, Tovaglieri I, et al. Kinetics of catecholamines and potassium, and heart rate during exercise testing in obese subjects. Heart rate regulation in obesity during exercise. European Journal of Nutrition. 2003; 42: 181\u2013187.","DOI":"10.1007\/s00394-003-0409-3"},{"key":"ref258","doi-asserted-by":"publisher","unstructured":"Gustafson AB, Farrell PA, Kalkhoff RK. Impaired plasma catecholamine response to submaximal treadmill exercise in obese women. Metabolism: Clinical and Experimental. 1990; 39: 410\u2013417.","DOI":"10.1016\/0026-0495(90)90257-d"},{"key":"ref259","doi-asserted-by":"publisher","unstructured":"Kruk J, Kotarska K, Aboul-Enein BH. Physical exercise and catecholamines response: benefits and health risk: possible mechanisms. Free Radical Research. 2020; 54: 105\u2013125.","DOI":"10.1080\/10715762.2020.1726343"},{"key":"ref260","doi-asserted-by":"publisher","unstructured":"Hansen D, Meeusen R, Mullens A, Dendale P. Effect of acute endurance and resistance exercise on endocrine hormones directly related to lipolysis and skeletal muscle protein synthesis in adult individuals with obesity. Sports Medicine (Auckland, N.Z.). 2012; 42: 415\u2013431.","DOI":"10.2165\/11599590-000000000-00000"},{"key":"ref261","doi-asserted-by":"publisher","unstructured":"Pirzgalska RM, Seixas E, Seidman JS, Link VM, S\u00e1nchez NM, Mah\u00fa I, et al. Sympathetic neuron-associated macrophages contribute to obesity by importing and metabolizing norepinephrine. Nature Medicine. 2017; 23: 1309\u20131318.","DOI":"10.1038\/nm.4422"},{"key":"ref262","doi-asserted-by":"publisher","unstructured":"Bayraktaroglu I, Ort\u00ed-Casa\u00f1 N, Van Dam D, De Deyn PP, Eisel ULM. Systemic inflammation as a central player in the initiation and development of Alzheimer\u2019s disease. Immunity & Ageing: i & a. 2025; 22: 33.","DOI":"10.1186\/s12979-025-00529-5"},{"key":"ref263","doi-asserted-by":"publisher","unstructured":"Xu WL, Atti AR, Gatz M, Pedersen NL, Johansson B, Fratiglioni L. Midlife overweight and obesity increase late-life dementia risk: a population-based twin study. Neurology. 2011; 76: 1568\u20131574.","DOI":"10.1212\/WNL.0b013e3182190d09"},{"key":"ref264","doi-asserted-by":"publisher","unstructured":"Whitmer RA, Gunderson EP, Barrett-Connor E, Quesenberry CP, Jr, Yaffe K. Obesity in middle age and future risk of dementia: a 27 year longitudinal population based study. BMJ (Clinical Research Ed.). 2005; 330: 1360.","DOI":"10.1136\/bmj.38446.466238.E0"},{"key":"ref265","doi-asserted-by":"publisher","unstructured":"Perry VH, Cunningham C, Holmes C. Systemic infections and inflammation affect chronic neurodegeneration. Nature Reviews. Immunology. 2007; 7: 161\u2013167.","DOI":"10.1038\/nri2015"},{"key":"ref266","doi-asserted-by":"publisher","unstructured":"Norden DM, Muccigrosso MM, Godbout JP. Microglial priming and enhanced reactivity to secondary insult in aging, and traumatic CNS injury, and neurodegenerative disease. Neuropharmacology. 2015; 96: 29\u201341.","DOI":"10.1016\/j.neuropharm.2014.10.028"},{"key":"ref267","doi-asserted-by":"publisher","unstructured":"Vogt NM, Kerby RL, Dill-McFarland KA, Harding SJ, Merluzzi AP, Johnson SC, et al. Gut microbiome alterations in Alzheimer\u2019s disease. Scientific Reports. 2017; 7: 13537.","DOI":"10.1038\/s41598-017-13601-y"},{"key":"ref268","doi-asserted-by":"publisher","unstructured":"Huang Y, Xu W, Zhou R. NLRP3 inflammasome activation and cell death. Cellular & Molecular Immunology. 2021; 18: 2114\u20132127.","DOI":"10.1038\/s41423-021-00740-6"},{"key":"ref269","doi-asserted-by":"publisher","unstructured":"Dellera F, Ganzetti GS, Froio A, Manzini S, Busnelli M, Meinitzer A, et al. L-homoarginine administration reduces neointimal hyperplasia in balloon-injured rat carotids. Thrombosis and Haemostasis. 2016; 116: 400\u2013402.","DOI":"10.1160\/TH15-10-0831"},{"key":"ref270","doi-asserted-by":"publisher","unstructured":"Knox EG, Aburto MR, Clarke G, Cryan JF, O\u2019Driscoll CM. The blood-brain barrier in aging and neurodegeneration. Molecular Psychiatry. 2022; 27: 2659\u20132673.","DOI":"10.1038\/s41380-022-01511-z"},{"key":"ref271","doi-asserted-by":"publisher","unstructured":"Izzo C, Carrizzo A, Alfano A, Virtuoso N, Capunzo M, Calabrese M, et al. The Impact of Aging on Cardio and Cerebrovascular Diseases. International Journal of Molecular Sciences. 2018; 19: 481.","DOI":"10.3390\/ijms19020481"},{"key":"ref272","doi-asserted-by":"publisher","unstructured":"Valenza G, Mati\u0107 Z, Catrambone V. The brain-heart axis: integrative cooperation of neural, mechanical and biochemical pathways. Nature Reviews. Cardiology. 2025; 22: 537\u2013550.","DOI":"10.1038\/s41569-025-01140-3"},{"key":"ref273","doi-asserted-by":"publisher","unstructured":"Saheb Kashaf S, Proctor DM, Deming C, Saary P, H\u00f6lzer M, NISC Comparative Sequencing Program, et al. Integrating cultivation and metagenomics for a multi-kingdom view of skin microbiome diversity and functions. Nature Microbiology. 2022; 7: 169\u2013179.","DOI":"10.1038\/s41564-021-01011-w"},{"key":"ref274","doi-asserted-by":"publisher","unstructured":"Cuber P, Chooneea D, Geeves C, Salatino S, Creedy TJ, Griffin C, et al. Comparing the accuracy and efficiency of third generation sequencing technologies, Oxford Nanopore Technologies, and Pacific Biosciences, for DNA barcode sequencing applications. Ecological Genetics and Genomics. 2023; 28: 100181.","DOI":"10.1016\/j.egg.2023.100181"},{"key":"ref275","doi-asserted-by":"publisher","unstructured":"Alexandrescu L, Tofolean IT, Condur LM, Tofolean DE, Nicoara AD, Serbanescu L, et al. Smart Microbiomes: How AI Is Revolutionizing Personalized Medicine. Bioengineering (Basel, Switzerland). 2025; 12: 944.","DOI":"10.3390\/bioengineering12090944"},{"key":"ref276","doi-asserted-by":"publisher","unstructured":"Mouton A, Blanc F, Gros A, Manera V, Fabre R, Sauleau E, et al. Sex ratio in dementia with Lewy bodies balanced between Alzheimer\u2019s disease and Parkinson\u2019s disease dementia: a cross-sectional study. Alzheimer\u2019s Research & Therapy. 2018; 10: 92.","DOI":"10.1186\/s13195-018-0417-4"}],"container-title":["Frontiers in Bioscience-Landmark"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.imrpress.com\/journal\/FBL\/31\/5\/10.31083\/FBL47174","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,30]],"date-time":"2026-05-30T07:26:10Z","timestamp":1780125970000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.imrpress.com\/journal\/FBL\/31\/5\/10.31083\/FBL47174"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,22]]},"references-count":276,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026]]}},"alternative-id":["S2768-6701(25)01931-8"],"URL":"https:\/\/doi.org\/10.31083\/fbl47174","relation":{},"ISSN":["2768-6701","2768-6698"],"issn-type":[{"value":"2768-6701","type":"print"},{"value":"2768-6698","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,22]]},"article-number":"47174"}}